{"recordsFiltered":50008,"recordsTotal":50008,"next":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=37500","previous":"http://staging-fdaaa.ebmdatalab.net/api/trials/?format=json&length=300&ordering=status&start=36900","results":[{"registry_id":"NCT05164094","publication_url":"https://clinicaltrials.gov/study/NCT05164094","title":"A Phase 1/2, Randomized, Observer-Blind, Placebo-Controlled, Dose-Ranging Study of an Epstein-Barr Virus (EBV) Candidate Vaccine, mRNA-1189, in 10- to 30-Year-Old Healthy Adolescents and Adults","has_exemption":false,"start_date":"2021-12-28","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"ModernaTX, Inc.","sponsor_slug":"modernatx-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05511363","publication_url":"https://clinicaltrials.gov/study/NCT05511363","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Relapse Prevention Study to Evaluate the Safety and Efficacy of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease","has_exemption":false,"start_date":"2022-08-23","completion_date":"2026-10-05","has_results":false,"results_due":false,"sponsor_name":"Karuna Therapeutics, Inc., a Bristol Myers Squibb company","sponsor_slug":"karuna-therapeutics-inc-a-bristol-myers-squibb-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05574101","publication_url":"https://clinicaltrials.gov/study/NCT05574101","title":"A Phase II, Multicenter, Single-Arm Clinical Trial of Definitive Response-Adapted Radiotherapy And CeMiPlimAb-Rwlc ImmunoTherapy for Locally Advanced, Unresectable Cutaneous Squamous Cell Carcinoma: RAMPART","has_exemption":false,"start_date":"2022-10-06","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06003426","publication_url":"https://clinicaltrials.gov/study/NCT06003426","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Phase 3 Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986278 in Participants With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2023-09-14","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04568837","publication_url":"https://clinicaltrials.gov/study/NCT04568837","title":"Postoperative Steroids and Recovery After Spine Fusion","has_exemption":false,"start_date":"2025-03-01","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Oregon Health and Science University","sponsor_slug":"oregon-health-and-science-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07298382","publication_url":"https://clinicaltrials.gov/study/NCT07298382","title":"See the Impact Beem's Blue Light Therapy Has on Your Skin Health!","has_exemption":false,"start_date":"2025-10-06","completion_date":"2026-10-06","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02612454","publication_url":"https://clinicaltrials.gov/study/NCT02612454","title":"An Open-Label Extension Study to Assess the Long-Term Safety and Efficacy of Dupilumab in Patients ≥6 Months to <18 Years of Age With Atopic Dermatitis","has_exemption":false,"start_date":"2015-10-15","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT06829914","publication_url":"https://clinicaltrials.gov/study/NCT06829914","title":"Shockwave™ vs Surgical Endarterectomy for Calcified Severe Common Femoral Artery Stenosis: Comparison of Efficacy, Safety and Long-Term Outcomes","has_exemption":false,"start_date":"2024-03-07","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Baylor Research Institute","sponsor_slug":"baylor-research-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07215104","publication_url":"https://clinicaltrials.gov/study/NCT07215104","title":"A Prospective Evaluation of Spinal Cord Induced Muscle Stimulation (MuscleSCS) for the Treatment of Chronic Low Back Pain","has_exemption":false,"start_date":"2025-10-07","completion_date":"2026-10-07","has_results":false,"results_due":false,"sponsor_name":"Saint Francis Hospital","sponsor_slug":"saint-francis-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05805501","publication_url":"https://clinicaltrials.gov/study/NCT05805501","title":"A Randomized Open Label Phase II Study of Immune Checkpoint Inhibitor Combinations With Axitinib in Patients With Previously Untreated Locally Advanced Unresectable or Metastatic Renal Cell Carcinoma","has_exemption":false,"start_date":"2023-04-21","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06332040","publication_url":"https://clinicaltrials.gov/study/NCT06332040","title":"A Randomized Controlled Trial to Evaluate the Effectiveness of Gentamicin Bladder Instillation on CAUTI","has_exemption":false,"start_date":"2023-10-09","completion_date":"2026-10-08","has_results":false,"results_due":false,"sponsor_name":"St. Joseph's Hospital and Medical Center, Phoenix","sponsor_slug":"st-josephs-hospital-and-medical-center-phoenix","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05202782","publication_url":"https://clinicaltrials.gov/study/NCT05202782","title":"Phase II, Single-Arm, Open-label, Multicenter Study Evaluating the Efficacy of Adjunctive Zanubrutinib and CAR T-Cell Therapy in Aggressive B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2022-03-21","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Northwestern University","sponsor_slug":"northwestern-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06958211","publication_url":"https://clinicaltrials.gov/study/NCT06958211","title":"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-12","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06959225","publication_url":"https://clinicaltrials.gov/study/NCT06959225","title":"A Phase 3, Double-Blind, Randomized, Vehicle-Controlled, Efficacy and Safety Study of Ruxolitinib Cream in Participants With Hidradenitis Suppurativa","has_exemption":false,"start_date":"2025-06-23","completion_date":"2026-10-09","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05367245","publication_url":"https://clinicaltrials.gov/study/NCT05367245","title":"Microbiome Targeted Oral Butyrate Therapy in Gulf War Multisymptom Illness","has_exemption":false,"start_date":"2024-01-15","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"VA Office of Research and Development","sponsor_slug":"va-office-of-research-and-development","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06976697","publication_url":"https://clinicaltrials.gov/study/NCT06976697","title":"Safety And Efficacy of Remotely Supervised Home-Based tDCS Treatment Of Major Depressive Disorder","has_exemption":false,"start_date":"2025-06-27","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Sooma Medical Inc","sponsor_slug":"sooma-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07193459","publication_url":"https://clinicaltrials.gov/study/NCT07193459","title":"A Phase 3, Randomized, Double-blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of HDM1002 Tablets in Subjects With Type 2 Diabetes Mellitus Inadequately Controlled With Diet and Exercise Only","has_exemption":false,"start_date":"2025-08-12","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.","sponsor_slug":"hangzhou-zhongmei-huadong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07092137","publication_url":"https://clinicaltrials.gov/study/NCT07092137","title":"Nano-crystalline Megestrol Acetate for Anorexia-Cachexia in Advanced Lung Cancer: A Randomized, Double-Blind, Multicenter Study","has_exemption":false,"start_date":"2025-10-10","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"Guangzhou Institute of Respiratory Disease","sponsor_slug":"guangzhou-institute-of-respiratory-disease","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07583823","publication_url":"https://clinicaltrials.gov/study/NCT07583823","title":"Elevated Rate Pacing of Cardiac Amyloidosis","has_exemption":false,"start_date":"2025-10-10","completion_date":"2026-10-10","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03821792","publication_url":"https://clinicaltrials.gov/study/NCT03821792","title":"A Phase 2 Course Determining Study for Men With Hormone-Naïve Metastatic Prostate Cancer (HNMPCa)","has_exemption":false,"start_date":"2019-07-22","completion_date":"2026-10-11","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05696184","publication_url":"https://clinicaltrials.gov/study/NCT05696184","title":"Pathophysiology of Pharyngo-esophageal Junction and Esophageal Mechanisms Preventing Pharyngeal Reflux of Gastric Content","has_exemption":false,"start_date":"2013-11-01","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT05133531","publication_url":"https://clinicaltrials.gov/study/NCT05133531","title":"A Randomized, Open-Label, C5 Inhibitor-Controlled Study to Evaluate the Efficacy and Safety of Pozelimab and Cemdisiran Combination Therapy in Patients With Paroxysmal Nocturnal Hemoglobinuria Who Are Complement Inhibitor Treatment-Naive or Have Not Recently Received Complement Inhibitor Therapy","has_exemption":false,"start_date":"2022-08-01","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Regeneron Pharmaceuticals","sponsor_slug":"regeneron-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05372354","publication_url":"https://clinicaltrials.gov/study/NCT05372354","title":"An Exploratory Phase 1b/2a Multicenter, Open-Label, Novel-Novel Combination Study to Assess the Safety, Pharmacokinetics, Pharmacodynamics, and Preliminary Efficacy of CC-92480 (BMS-986348) in Novel Therapeutic Combinations in Participants With Relapsed or Refractory Multiple Myeloma","has_exemption":false,"start_date":"2022-10-18","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05884398","publication_url":"https://clinicaltrials.gov/study/NCT05884398","title":"A Phase 3, Open-label, Randomized, Prospective Study of Apalutamide With Continued Versus Intermittent Androgen-Deprivation Therapy (ADT) Following PSA Response in Participants With Metastatic Castration-Sensitive Prostate Cancer (mCSPC)","has_exemption":false,"start_date":"2023-08-31","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07768475","publication_url":"https://clinicaltrials.gov/study/NCT07768475","title":"A Prospective Study Comparing Visual Outcomes and Patient Satisfaction Following Implantation of the Clareon PanOptix Versus Tecnis Odyssey IOL in Patients Undergoing Cataract Surgery.","has_exemption":false,"start_date":"2025-07-07","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Nvision Laser Eye Centers","sponsor_slug":"nvision-laser-eye-centers","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07523412","publication_url":"https://clinicaltrials.gov/study/NCT07523412","title":"Dimensional Changes of Peri-implant Tissues Following Jumping Gap Grafting Using Erythropoietin Gel Mixed With Xenograft. (A Randomized Controlled Clinical Study)","has_exemption":false,"start_date":"2026-04-12","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Ain Shams University","sponsor_slug":"ain-shams-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07677514","publication_url":"https://clinicaltrials.gov/study/NCT07677514","title":"A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase II Clinical Study to Evaluate the Efficacy and Safety of H021 Enteric-coated Tablets in Patients With Moderately to Severely Active Crohn's Disease (CD)","has_exemption":false,"start_date":"2026-07-12","completion_date":"2026-10-12","has_results":false,"results_due":false,"sponsor_name":"Jiangsu Carephar Pharmaceutical Co., Ltd.","sponsor_slug":"jiangsu-carephar-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04998396","publication_url":"https://clinicaltrials.gov/study/NCT04998396","title":"A Phase 1/2 Open-Label Study of the Safety and Clinical Activity of Gene Therapy for Canavan Disease Through Administration of an Adeno-Associated Virus (AAV) Serotype 9-Based Recombinant Vector Encoding the Human ASPA Gene","has_exemption":false,"start_date":"2021-09-08","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"Aspa Therapeutics","sponsor_slug":"aspa-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05389215","publication_url":"https://clinicaltrials.gov/study/NCT05389215","title":"A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety and Efficacy of DWN12088 in Patients With Idiopathic Pulmonary Fibrosis","has_exemption":false,"start_date":"2022-07-29","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"Daewoong Pharmaceutical Co. LTD.","sponsor_slug":"daewoong-pharmaceutical-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06521567","publication_url":"https://clinicaltrials.gov/study/NCT06521567","title":"Phase 1/2 Dose Determination and Dose Expansion Study of Cobolimab in Combination With Dostarlimab in Pediatric and Young Adult Participants With Newly Diagnosed and Relapsed/Refractory Tumors (POPSTAR)","has_exemption":false,"start_date":"2025-03-06","completion_date":"2026-10-13","has_results":false,"results_due":false,"sponsor_name":"GlaxoSmithKline","sponsor_slug":"glaxosmithkline","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03707340","publication_url":"https://clinicaltrials.gov/study/NCT03707340","title":"A Feasibility Study of Flibanserin in Breast Cancer Survivors on Tamoxifen and Aromatase Inhibitors","has_exemption":false,"start_date":"2018-09-14","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06834347","publication_url":"https://clinicaltrials.gov/study/NCT06834347","title":"A Randomized, Double-blind, Placebo-controlled, Parallel-group, 52-week Phase 3 Trial to Investigate the Efficacy, Safety, and Tolerability of Itepekimab in Adult Participants With Inadequately-controlled Chronic Rhinosinusitis With Nasal Polyps","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Sanofi","sponsor_slug":"sanofi","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07473973","publication_url":"https://clinicaltrials.gov/study/NCT07473973","title":"The ENERGY 2 Study: An Open-Label Phase 3 Study to Evaluate the Efficacy and Safety of INZ-701 in Infants With Ectonucleotide Pyrophosphatase/Phosphodiesterase 1 (ENPP1) Deficiency","has_exemption":false,"start_date":"2025-03-26","completion_date":"2026-10-14","has_results":false,"results_due":false,"sponsor_name":"Inozyme Pharma","sponsor_slug":"inozyme-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03368742","publication_url":"https://clinicaltrials.gov/study/NCT03368742","title":"A Randomized, Controlled, Open-label, Single-ascending Dose, Phase I/II Study to Investigate the Safety and Tolerability, and Efficacy of Intravenous SGT-001 in Male Adolescents and Children With Duchenne Muscular Dystrophy","has_exemption":false,"start_date":"2017-12-06","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Solid Biosciences Inc.","sponsor_slug":"solid-biosciences-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04144894","publication_url":"https://clinicaltrials.gov/study/NCT04144894","title":"The Biosonographic Index - A Novel Index for the Early Detection of Acute Kidney Injury After Vascular Surgery - an Exploratory Study.","has_exemption":false,"start_date":"2020-01-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05455697","publication_url":"https://clinicaltrials.gov/study/NCT05455697","title":"Immunostart: Prephase Tafasitamab, Retifanlimab, and Rituximab (TRR), Followed by TRR With Standard Therapy for Previously Untreated Diffuse Large B-Cell Lymphoma","has_exemption":false,"start_date":"2023-01-26","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05605535","publication_url":"https://clinicaltrials.gov/study/NCT05605535","title":"A Phase 2, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial Comparing Chemoimmunotherapy (Paclitaxel-Carboplatin-Oregovomab) Versus Chemotherapy (Paclitaxel-Carboplatin-Placebo) as Neoadjuvant Therapy in Patients With Advanced Epithelial Ovarian, Fallopian Tube or Peritoneal Carcinoma","has_exemption":false,"start_date":"2023-02-07","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"CanariaBio Inc.","sponsor_slug":"canariabio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06720350","publication_url":"https://clinicaltrials.gov/study/NCT06720350","title":"Efficacy of Romosozumab and Denosumab Combined Treatment in Postmenopausal Osteoporosis Patients with Multiple Fragility Fractures","has_exemption":false,"start_date":"2025-01-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Marmara University","sponsor_slug":"marmara-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06894511","publication_url":"https://clinicaltrials.gov/study/NCT06894511","title":"A Phase II, Open-label, Multi-Center, Randomized Study of Combination of Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) and Androgen Receptor Pathway Inhibitor (ARPI) vs. Lutetium (177Lu) Vipivotide Tetraxetan (AAA617) in First-line Treatment of Patients With Prostate-Specific Membrane Antigen (PSMA)-Positive Progressive Metastatic Castration Resistant Prostate Cancer (mCRPC)","has_exemption":false,"start_date":"2025-09-11","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07505303","publication_url":"https://clinicaltrials.gov/study/NCT07505303","title":"A Phase 2a, Randomized, Double-blind, Placebo-controlled Trial to Evaluate the Efficacy, Safety, and Tolerability of ECC4703 as an Adjunct to Semaglutide in Adults With Obesity","has_exemption":false,"start_date":"2026-03-23","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Eccogene","sponsor_slug":"eccogene","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07497672","publication_url":"https://clinicaltrials.gov/study/NCT07497672","title":"Evaluation of Novel Spectacles Intended for Myopia Management in a Short-Term Study","has_exemption":false,"start_date":"2026-04-15","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Myoptechs, Inc","sponsor_slug":"myoptechs-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07545980","publication_url":"https://clinicaltrials.gov/study/NCT07545980","title":"Open-Label Proof-of-Concept Study of CelluJuve® for the Treatment of Moderate to Severe Nasolabial Folds","has_exemption":false,"start_date":"2026-04-29","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Spiderwort Biotechnologies Inc.","sponsor_slug":"spiderwort-biotechnologies-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07111494","publication_url":"https://clinicaltrials.gov/study/NCT07111494","title":"Impact of Glucagon-like Peptide-1 (GLP-1) Analogs on Disease Outcomes in Psoriatic Arthritis: A Pragmatic Randomized Controlled Trial","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"Medical College of Wisconsin","sponsor_slug":"medical-college-of-wisconsin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07717840","publication_url":"https://clinicaltrials.gov/study/NCT07717840","title":"A Phase I/II, Randomized, Double-Blind, Active-Controlled Study to Characterize the Safety and Immunogenicity of AZD6489 in Adults 60 Years of Age and Older","has_exemption":false,"start_date":"2026-07-08","completion_date":"2026-10-15","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03533283","publication_url":"https://clinicaltrials.gov/study/NCT03533283","title":"An Open-Label, Multi-Center, Phase IB/II Study of Glofitamab and Atezolizumab or Polatuzumab Vedotin (Plus a Single Pre-Treatment Dose of Obinutuzumab) in Adult Patients With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma","has_exemption":false,"start_date":"2018-05-08","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05977907","publication_url":"https://clinicaltrials.gov/study/NCT05977907","title":"Neoadjuvant Pembrolizumab and IO102-103 Prior to Curative-intent Surgical Care for Squamous Cell Carcinoma of the Head and Neck (SCCHN)","has_exemption":false,"start_date":"2023-12-14","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06054776","publication_url":"https://clinicaltrials.gov/study/NCT06054776","title":"A Phase 2 Study of Glofitamab With Acalabrutinib in Patients With Relapsed/Refractory Mantle Cell Lymphoma","has_exemption":false,"start_date":"2024-12-02","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06671002","publication_url":"https://clinicaltrials.gov/study/NCT06671002","title":"Comparing Analgesic Regimen Effectiveness and Safety for Surgery for Kids (CARES for Kids) Trial","has_exemption":false,"start_date":"2025-01-10","completion_date":"2026-10-16","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07033585","publication_url":"https://clinicaltrials.gov/study/NCT07033585","title":"Generic Drugs (Dapagliflozin and Saxagliptin) Treat Type 2 Diabetes Patients With Controlled Cancers","has_exemption":false,"start_date":"2025-06-15","completion_date":"2026-10-18","has_results":false,"results_due":false,"sponsor_name":"Han Xu, M.D., Ph.D., FAPCR, Sponsor-Investigator, IRB Chair","sponsor_slug":"han-xu-md-phd-fapcr-sponsor-investigator-irb-chair","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03953300","publication_url":"https://clinicaltrials.gov/study/NCT03953300","title":"A Phase 4, Multicenter, Randomized, Double-blind, Parallel Group, Placebo Controlled Study to Evaluate the Effect of Benralizumab on Structural and Lung Function Changes in Severe Eosinophilic Asthmatics","has_exemption":false,"start_date":"2019-10-08","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05100472","publication_url":"https://clinicaltrials.gov/study/NCT05100472","title":"Phase II Trial of Short Course Androgen Deprivation, Hypofractionated Pelvic Radiation and a Brachytherapy Boost for NCCN High-Risk Prostate Cancer With Low-Intermediate Risk Decipher Genomic Score","has_exemption":false,"start_date":"2021-10-19","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05617677","publication_url":"https://clinicaltrials.gov/study/NCT05617677","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-1)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05620407","publication_url":"https://clinicaltrials.gov/study/NCT05620407","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Deucravacitinib in Participants With Active Systemic Lupus Erythematosus (SLE) (POETYK SLE-2)","has_exemption":false,"start_date":"2023-01-12","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Bristol-Myers Squibb","sponsor_slug":"bristol-myers-squibb","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05995964","publication_url":"https://clinicaltrials.gov/study/NCT05995964","title":"A PHASE 2, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO INVESTIGATE THE EFFICACY AND SAFETY OF PF-07275315 AND PF-07264660 IN ADULT PARTICIPANTS WITH MODERATE-SEVERE ATOPIC DERMATITIS","has_exemption":false,"start_date":"2023-08-22","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Pfizer","sponsor_slug":"pfizer","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516952","publication_url":"https://clinicaltrials.gov/study/NCT06516952","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06516965","publication_url":"https://clinicaltrials.gov/study/NCT06516965","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Efficacy and Safety Study of Povorcitinib in Participants With Prurigo Nodularis","has_exemption":false,"start_date":"2024-10-10","completion_date":"2026-10-19","has_results":false,"results_due":false,"sponsor_name":"Incyte Corporation","sponsor_slug":"incyte-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05531565","publication_url":"https://clinicaltrials.gov/study/NCT05531565","title":"A 2-Part Seamless Part A (Phase 2)/Part B (Phase 3) Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Evaluate the Efficacy and Safety of BIIB059 in Participants With Active Subacute Cutaneous Lupus Erythematosus and/or Chronic Cutaneous Lupus Erythematosus With or Without Systemic Manifestations and Refractory and/or Intolerant to Antimalarial Therapy (AMETHYST)","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Biogen","sponsor_slug":"biogen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05875168","publication_url":"https://clinicaltrials.gov/study/NCT05875168","title":"Phase 1/2, Open-label, Multicenter, First-in-Human Study of DS-3939a in Subjects With Advanced Solid Tumors","has_exemption":false,"start_date":"2023-08-18","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Daiichi Sankyo","sponsor_slug":"daiichi-sankyo","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06311682","publication_url":"https://clinicaltrials.gov/study/NCT06311682","title":"A Phase 3 Multi-center Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children (Age 2 to <12 Years) and Infants (Age 6 Months to <2 Years) With Moderate-to-severe Atopic Dermatitis. The Trial is Randomized, Double-blind, Placebo-controlled, and Parallel-group for Children (Age 2 to <12 Years) and Open-label and Single-group for Infants (Age 6 Months to <2 Years)","has_exemption":false,"start_date":"2024-06-10","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"LEO Pharma","sponsor_slug":"leo-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07775248","publication_url":"https://clinicaltrials.gov/study/NCT07775248","title":"Novel Extended-Release Bupivacaine Polymer for Sustained Pain Relief Following Total Knee Arthroplasty","has_exemption":false,"start_date":"2025-02-11","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Henry Ford Health System","sponsor_slug":"henry-ford-health-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06894212","publication_url":"https://clinicaltrials.gov/study/NCT06894212","title":"A Phase 3, Randomized, Double-blind, Parallel-group, Placebo-controlled, Multicenter Trial to Evaluate the Efficacy and Safety of SEP-363856 in Acutely Psychotic Participants With Schizophrenia","has_exemption":false,"start_date":"2025-02-28","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Otsuka Pharmaceutical Development & Commercialization, Inc.","sponsor_slug":"otsuka-pharmaceutical-development-commercialization-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06795048","publication_url":"https://clinicaltrials.gov/study/NCT06795048","title":"A Phase IIIb/IV, Multicenter, Randomized, Open-Label, Two-Arm Study to Investigate the Efficacy, Safety, and Durability of Faricimab Administered up to Every 24 Weeks in Patients With Neovascular Age-Related Macular Degeneration","has_exemption":false,"start_date":"2025-03-14","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07122843","publication_url":"https://clinicaltrials.gov/study/NCT07122843","title":"Real Time Guided Meditations for Pain in Virtual Reality Study","has_exemption":false,"start_date":"2025-11-06","completion_date":"2026-10-20","has_results":false,"results_due":false,"sponsor_name":"Christopher Almario","sponsor_slug":"christopher-almario","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03587311","publication_url":"https://clinicaltrials.gov/study/NCT03587311","title":"A Randomized Phase 2 Study of Bevacizumab and Either Weekly Anetumab Ravtansine or Weekly Paclitaxel in Platinum-Resistant or Platinum Refractory Ovarian Cancer","has_exemption":false,"start_date":"2018-10-12","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05208307","publication_url":"https://clinicaltrials.gov/study/NCT05208307","title":"Maintenance Therapy With Belantamab, Pomalidomide and Dexamethasone (BPd) in High-Risk Myeloma Patients: A Phase 2 Study With a Safety Run-In","has_exemption":false,"start_date":"2022-07-21","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668766","publication_url":"https://clinicaltrials.gov/study/NCT06668766","title":"Superior Ultrasound-Guided Venous Access: Single-Lumen Midline Catheters vs Long Peripheral IVs for Difficult IV Access in the Emergency Department, A Randomized Controlled Trial","has_exemption":false,"start_date":"2025-01-01","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Albany Medical College","sponsor_slug":"albany-medical-college","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07282275","publication_url":"https://clinicaltrials.gov/study/NCT07282275","title":"How Does Continued Use of Green Light Therapy Impact Outcomes?","has_exemption":false,"start_date":"2025-10-21","completion_date":"2026-10-21","has_results":false,"results_due":false,"sponsor_name":"Efforia, Inc","sponsor_slug":"efforia-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03523858","publication_url":"https://clinicaltrials.gov/study/NCT03523858","title":"An Open-Label, Single-Arm 4-Year Study to Evaluate Effectiveness and Safety of Ocrelizumab Treatment in Patients With Progressive Multiple Sclerosis","has_exemption":false,"start_date":"2018-05-28","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04992624","publication_url":"https://clinicaltrials.gov/study/NCT04992624","title":"Cannabinoid Interactions With Central and Peripheral Pain Mechanisms in Osteoarthritis of the Knee","has_exemption":false,"start_date":"2022-02-22","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Steven E Harte, PhD","sponsor_slug":"steven-e-harte-phd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05468697","publication_url":"https://clinicaltrials.gov/study/NCT05468697","title":"A Multicenter, Open-label, Randomized, Phase 1/2 Study of Belzutifan in Combination With Palbociclib Versus Belzutifan Monotherapy in Participants With Advanced Renal Cell Carcinoma","has_exemption":false,"start_date":"2022-08-10","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05660980","publication_url":"https://clinicaltrials.gov/study/NCT05660980","title":"Phase I/II Study of the Safety, Tolerability, Acceptability, and Pharmacokinetics of Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in Virologically Suppressed Children Living With HIV-1, Two to Less Than 12 Years of Age","has_exemption":false,"start_date":"2024-01-24","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06245408","publication_url":"https://clinicaltrials.gov/study/NCT06245408","title":"A Phase 3 Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Dazodalibep in Participants With Sjögren's Syndrome With Moderate-to-Severe Symptom State (HZNP-DAZ-303)","has_exemption":false,"start_date":"2024-04-08","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07403669","publication_url":"https://clinicaltrials.gov/study/NCT07403669","title":"Cardiovascular Kidney and Metaboolic (CKM) Health Assessment and Patient Empowerment in chROnic Disease Using a Health Coach INtervention ModEl: A Randomized Clinical Trial","has_exemption":false,"start_date":"2025-10-22","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"Aventyn, Inc.","sponsor_slug":"aventyn-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07756385","publication_url":"https://clinicaltrials.gov/study/NCT07756385","title":"Comparison of Ultrasound Efficiency and Early Postoperative Outcomes of Two Phacoemulsification Systems (UNITY VCS 4D Phaco and Centurion With Active Sentry Probe): A Randomized Contralateral Eye Study","has_exemption":false,"start_date":"2026-08-06","completion_date":"2026-10-22","has_results":false,"results_due":false,"sponsor_name":"University Hospital Sveti Duh","sponsor_slug":"university-hospital-sveti-duh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05859334","publication_url":"https://clinicaltrials.gov/study/NCT05859334","title":"A Phase 2 Study of Erdafitinib in Patients With Recurrent or Progressive IDH-Wild Type Glioma With an FGFR-TACC Gene Fusion","has_exemption":false,"start_date":"2024-01-04","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06008093","publication_url":"https://clinicaltrials.gov/study/NCT06008093","title":"A Phase IIb, Randomized, Multicenter, Open-label Study to Assess the Efficacy of Durvalumab Plus Tremelimumab Versus Pembrolizumab in Combination With Platinum-based Chemotherapy for First-line Treatment in Metastatic Non-small Cell Lung Cancer Patients With Non-squamous Histology Who Have Mutations and/or Co-mutations in STK11, KEAP1, or KRAS (TRITON)","has_exemption":false,"start_date":"2024-04-04","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07230964","publication_url":"https://clinicaltrials.gov/study/NCT07230964","title":"Early Feasibility Study of the Correlation Between an Impedance Cardiography Test for Decompensation and the Development of Left Ventricular Replacement Fibrosis","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-10-23","has_results":false,"results_due":false,"sponsor_name":"Dermed Diagnostics, Inc.","sponsor_slug":"dermed-diagnostics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07221682","publication_url":"https://clinicaltrials.gov/study/NCT07221682","title":"Comparison For Ease Of Spinal Positioning & Duration Of Post-Op Analgesia Between Ultrasound Guided Supra-Inguinal Fascia Iliaca Block Vs Ultrasound Guided Infra-Inguinal Fascia Iliaca Block In Patients Undergoing Thigh & Knee Surgeries","has_exemption":false,"start_date":"2024-05-06","completion_date":"2026-10-25","has_results":false,"results_due":false,"sponsor_name":"Sahiwal medical college sahiwal","sponsor_slug":"sahiwal-medical-college-sahiwal","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04204616","publication_url":"https://clinicaltrials.gov/study/NCT04204616","title":"A Prospective, Multicenter, Long-Term Study to Assess the Safety and Efficacy of Nemolizumab (CD14152) in Subjects With Prurigo Nodularis","has_exemption":false,"start_date":"2021-01-11","completion_date":"2026-10-26","has_results":false,"results_due":false,"sponsor_name":"Galderma R&D","sponsor_slug":"galderma-rd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05360446","publication_url":"https://clinicaltrials.gov/study/NCT05360446","title":"A Multi-center, Randomized, Double-blind, Placebo-controlled, Parallel-group Phase IIIb Study Evaluating the Effect of Inclisiran on Atherosclerotic Plaque Progression Assessed by Coronary Computed Tomography Angiography (CCTA) in Participants With a Diagnosis of Non-obstructive Coronary Artery Disease Without Previous Cardiovascular Events (VICTORION-PLAQUE)","has_exemption":false,"start_date":"2022-07-08","completion_date":"2026-10-26","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05775159","publication_url":"https://clinicaltrials.gov/study/NCT05775159","title":"A Phase II, Open-Label, Multi-Drug, Multi-Center, Master Protocol to Evaluate the Efficacy and Safety of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer (GEMINI-Hepatobiliary)","has_exemption":false,"start_date":"2023-04-24","completion_date":"2026-10-27","has_results":false,"results_due":false,"sponsor_name":"AstraZeneca","sponsor_slug":"astrazeneca","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06789757","publication_url":"https://clinicaltrials.gov/study/NCT06789757","title":"An Open Label Phase II Study of Atezolizumab, Bevacizumab and Memantine in Patients With Hepatocellular Carcinoma","has_exemption":false,"start_date":"2025-02-25","completion_date":"2026-10-27","has_results":false,"results_due":false,"sponsor_name":"Inova Health Care Services","sponsor_slug":"inova-health-care-services","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05168930","publication_url":"https://clinicaltrials.gov/study/NCT05168930","title":"A Phase 2 Trial of Zanubrutinib and Venetoclax in Previously Treated CLL/SLL Patients","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05239728","publication_url":"https://clinicaltrials.gov/study/NCT05239728","title":"A Multicenter, Double-blind, Randomized Phase 3 Study to Compare the Efficacy and Safety of Belzutifan (MK-6482) Plus Pembrolizumab (MK-3475) Versus Placebo Plus Pembrolizumab in the Adjuvant Treatment of Clear Cell Renal Cell Carcinoma (ccRCC) Post Nephrectomy (MK-6482-022)","has_exemption":false,"start_date":"2022-03-15","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Merck Sharp & Dohme LLC","sponsor_slug":"merck-sharp-dohme-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05115110","publication_url":"https://clinicaltrials.gov/study/NCT05115110","title":"A Two-Part, Seamless, Multi-Center, Randomized, Placebo-Controlled, Double-Blind Study to Investigate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Patients With Spinal Muscular Atrophy","has_exemption":false,"start_date":"2022-06-02","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06722157","publication_url":"https://clinicaltrials.gov/study/NCT06722157","title":"Randomized, Double-masked, Active-controlled, Multicenter Study to Evaluate Efficacy and Safety of Two Regimens of Intravitreal BI 771716 Against Pegcetacoplan in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration VERDANT Trial","has_exemption":false,"start_date":"2025-01-06","completion_date":"2026-10-28","has_results":false,"results_due":false,"sponsor_name":"Boehringer Ingelheim","sponsor_slug":"boehringer-ingelheim","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05653349","publication_url":"https://clinicaltrials.gov/study/NCT05653349","title":"A Phase III, Randomized, Double-blind Study of Ianalumab (VAY736) Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (VAYHIT1)","has_exemption":false,"start_date":"2023-02-03","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Novartis Pharmaceuticals","sponsor_slug":"novartis-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06260033","publication_url":"https://clinicaltrials.gov/study/NCT06260033","title":"A Phase II Trial of Stereotactic Body Radiation Therapy and Fluoroestradiol Positron Emission Tomography in Patients With Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer","has_exemption":false,"start_date":"2024-07-23","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"City of Hope Medical Center","sponsor_slug":"city-of-hope-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06668376","publication_url":"https://clinicaltrials.gov/study/NCT06668376","title":"A Study to Evaluate the Incrediwear Products Immediately After ACL or ACL+MCL Arthroscopic Surgery","has_exemption":false,"start_date":"2024-10-29","completion_date":"2026-10-29","has_results":false,"results_due":false,"sponsor_name":"Texas Bone and Joint","sponsor_slug":"texas-bone-and-joint","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02843035","publication_url":"https://clinicaltrials.gov/study/NCT02843035","title":"A 4-part, Open-label, Multicenter, Multinational Study of the Safety, Tolerability, Pharmacokinetics, Pharmacodynamic, and Exploratory Efficacy of Venglustat in Combination With Cerezyme in Adult Patients With Gaucher Disease Type 3 With Venglustat Monotherapy Extension","has_exemption":false,"start_date":"2017-01-04","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Genzyme, a Sanofi Company","sponsor_slug":"genzyme-a-sanofi-company","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03114865","publication_url":"https://clinicaltrials.gov/study/NCT03114865","title":"A Phase IB/II Study of Blinatumomab in Patients With Pre B-cell Acute Lymphoblastic Leukemia (ALL) and B-cell Non-Hodgkin Lymphoma (NHL) as Post-allogeneic Stem Cell Transplant (Allo-HSCT) Remission Maintenance","has_exemption":false,"start_date":"2017-09-05","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04041310","publication_url":"https://clinicaltrials.gov/study/NCT04041310","title":"A Phase I/II, Multicenter, Open-Label Study of Nous-209 Genetic Vaccine for the Treatment of Microsatellite Unstable Solid Tumors","has_exemption":false,"start_date":"2019-10-21","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Nouscom SRL","sponsor_slug":"nouscom-srl","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04565665","publication_url":"https://clinicaltrials.gov/study/NCT04565665","title":"Study of Cord Blood Derived Mesenchymal Stem Cells for Treatment of Moderate, Severe or Critical Pneumonia","has_exemption":false,"start_date":"2020-07-29","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04582279","publication_url":"https://clinicaltrials.gov/study/NCT04582279","title":"Application of Lung Ultrasound Artefact Analysis for Exclusion of Acute Rejection in Asymptomatic Lung Transplant Recipients","has_exemption":false,"start_date":"2020-10-28","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04675710","publication_url":"https://clinicaltrials.gov/study/NCT04675710","title":"Pembrolizumab in Combination With Dabrafenib and Trametinib as a Neoadjuvant Strategy Prior to Surgery in BRAF-Mutated Anaplastic Thyroid Cancer","has_exemption":false,"start_date":"2021-06-24","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04793412","publication_url":"https://clinicaltrials.gov/study/NCT04793412","title":"Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05007873","publication_url":"https://clinicaltrials.gov/study/NCT05007873","title":"Phase II Study Assessing Safety and Clinical Activity of the Combination of ASTX727 With Dasatinib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP)","has_exemption":false,"start_date":"2021-10-21","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04851613","publication_url":"https://clinicaltrials.gov/study/NCT04851613","title":"A Phase Ib/III Study to Evaluate the Efficacy and Safety of Afuresertib Plus Fulvestrant in Patients With Locally Advanced or Metastatic HR+/HER2- Breast Cancer Who Failed Standard of Care Therapies","has_exemption":false,"start_date":"2022-02-18","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Laekna Limited","sponsor_slug":"laekna-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05444257","publication_url":"https://clinicaltrials.gov/study/NCT05444257","title":"A Phase 3, Open-label Study Evaluating the Long-term Safety and Efficacy of VX-121/TEZ/D-IVA Combination Therapy in Subjects With Cystic Fibrosis","has_exemption":false,"start_date":"2022-11-08","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Vertex Pharmaceuticals Incorporated","sponsor_slug":"vertex-pharmaceuticals-incorporated","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05293600","publication_url":"https://clinicaltrials.gov/study/NCT05293600","title":"Treating Residual OSA With Endotype-directed Pharmacotherapy (Aim 3)","has_exemption":false,"start_date":"2023-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05972018","publication_url":"https://clinicaltrials.gov/study/NCT05972018","title":"Liposomal Bupivacaine/Bupivacaine A Single-Dose Bilateral Rectus Sheath Blocks Versus Ropivacaine in Bilateral Rectus Sheath Blocks And Catheters With Intermittent Hourly Boluses.","has_exemption":false,"start_date":"2023-10-18","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Hartford Hospital","sponsor_slug":"hartford-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05853575","publication_url":"https://clinicaltrials.gov/study/NCT05853575","title":"A Randomized Study of Two Dosing Regimens of Adagrasib in Patients With Previously Treated Non-Small Cell Lung Cancer With KRAS G12C Mutation","has_exemption":false,"start_date":"2024-02-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Mirati Therapeutics Inc.","sponsor_slug":"mirati-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06385925","publication_url":"https://clinicaltrials.gov/study/NCT06385925","title":"Phase 1/2 Study of TSN1611 in Subjects With Advanced Solid Tumors Harboring KRAS G12D Mutation","has_exemption":false,"start_date":"2024-04-29","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Tyligand Pharmaceuticals (Suzhou) Limited","sponsor_slug":"tyligand-pharmaceuticals-suzhou-limited","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06218706","publication_url":"https://clinicaltrials.gov/study/NCT06218706","title":"A Randomized, Sham-Controlled Trial Investigating Low Intensity Focused Ultrasound as a Novel Treatment for Refractory Opioid Use Disorder","has_exemption":false,"start_date":"2024-05-09","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Ali Rezai","sponsor_slug":"ali-rezai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06233799","publication_url":"https://clinicaltrials.gov/study/NCT06233799","title":"Randomized, Placebo-Controlled, Multi-Site Trial of Extended-Release Naltrexone Injection/Bupropion XL Tablets in the Treatment of Methamphetamine Use Disorder","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"National Institute on Drug Abuse (NIDA)","sponsor_slug":"national-institute-on-drug-abuse-nida","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06143306","publication_url":"https://clinicaltrials.gov/study/NCT06143306","title":"Addition of a Pectoserratus Block to Interscalene Block in Patients Undergoing Total Shoulder Replacement","has_exemption":false,"start_date":"2024-08-14","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06591650","publication_url":"https://clinicaltrials.gov/study/NCT06591650","title":"A Phase II Study of Gemcitabine, Cisplatin, Nab-Paclitaxel, and Durvalumab in Locally Advanced or Metastatic Gallbladder Cancer","has_exemption":false,"start_date":"2024-10-24","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Fudan University","sponsor_slug":"fudan-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06641765","publication_url":"https://clinicaltrials.gov/study/NCT06641765","title":"Continuous Glucose Monitoring in Haemodialysis and Peritoneal Dialysis Patients With Type 1 and Type 2 Diabetes","has_exemption":false,"start_date":"2024-11-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Bo Feldt-Rasmussen","sponsor_slug":"bo-feldt-rasmussen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06446765","publication_url":"https://clinicaltrials.gov/study/NCT06446765","title":"Mindfulness-based Neurofeedback to Augment Dialectical Behavior Therapy (DBT) for Adults With Borderline Personality Disorder (Aim 1)","has_exemption":false,"start_date":"2025-03-13","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06923891","publication_url":"https://clinicaltrials.gov/study/NCT06923891","title":"An Open-Label Study to Evaluate the Efficacy and Tolerability of Xanomeline/Trospium In First Episode/Early Phase Schizophrenia Patients","has_exemption":false,"start_date":"2025-04-16","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Vanguard Research Group","sponsor_slug":"vanguard-research-group","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06965621","publication_url":"https://clinicaltrials.gov/study/NCT06965621","title":"An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With Heart Failure and Implantable Cardioverter-Defibrillators","has_exemption":false,"start_date":"2025-11-05","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","sponsor_slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07701512","publication_url":"https://clinicaltrials.gov/study/NCT07701512","title":"Clinical Study to Evaluate the Efficacy of Febuxostat in the Treatment of Conservatively Managed Intracranial Hemorrhage Patients","has_exemption":false,"start_date":"2025-11-20","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Tanta University","sponsor_slug":"tanta-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07240831","publication_url":"https://clinicaltrials.gov/study/NCT07240831","title":"Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring","has_exemption":false,"start_date":"2025-12-15","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Biobeat Technologies Ltd.","sponsor_slug":"biobeat-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07005050","publication_url":"https://clinicaltrials.gov/study/NCT07005050","title":"Renal Pelvic Denervation Pilot Trial","has_exemption":false,"start_date":"2025-12-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Verve Medical, Inc","sponsor_slug":"verve-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07312006","publication_url":"https://clinicaltrials.gov/study/NCT07312006","title":"Comparison of AirSeal to DV5 Insufflation in Gastric Sleeve Procedures - The \"CAT5-GS\" Study","has_exemption":false,"start_date":"2026-01-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"SurgiQuest, Inc.","sponsor_slug":"surgiquest-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07178210","publication_url":"https://clinicaltrials.gov/study/NCT07178210","title":"Robotic-Enabled Microsurgical Intervention for Neurodegenerative Disease - A Global, Prospective, Early Feasibility Study in Alzheimer's Patients","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"MMI (Medical Microinstruments, Inc.)","sponsor_slug":"mmi-medical-microinstruments-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07176286","publication_url":"https://clinicaltrials.gov/study/NCT07176286","title":"An Open-Label, Exploratory, Phase 2 Scintigraphy Study Evaluating 18F-mFBG for Imaging Myocardial Sympathetic Innervation in Subjects With and Without Lewy Body Diseases","has_exemption":false,"start_date":"2026-04-30","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)","sponsor_slug":"innervate-radiopharmaceuticals-llc-formerly-illumina-radiopharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07288047","publication_url":"https://clinicaltrials.gov/study/NCT07288047","title":"Virtual Reality as an Adjunctive Agent for the Management of Pain and Anxiety During First Trimester Procedural Abortion: a Randomized Controlled Trial","has_exemption":false,"start_date":"2026-05-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Study Investigator","sponsor_slug":"study-investigator","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07434986","publication_url":"https://clinicaltrials.gov/study/NCT07434986","title":"Overnight Temporal Interference Stimulation of Bilateral Hippocampi to Reduce Epileptogenic Biomarkers and Improve Sleep in Temporal Lobe Epilepsy","has_exemption":false,"start_date":"2026-06-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07419009","publication_url":"https://clinicaltrials.gov/study/NCT07419009","title":"Evaluating Frontal Pole as a Window to Modulation of Cognitive Control in OCD","has_exemption":false,"start_date":"2026-06-15","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06906471","publication_url":"https://clinicaltrials.gov/study/NCT06906471","title":"A Single-Arm, Blinded, Fluorescent PSMA Histopathology Trial of AS1986NS","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Antelope Surgical Solutions, Inc","sponsor_slug":"antelope-surgical-solutions-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07400666","publication_url":"https://clinicaltrials.gov/study/NCT07400666","title":"Intra-gastrointestinal Monitoring Device (PressureDOT®) and Centurion Intra-abdominal Pressure Monitoring Device Comparison Study: Pivotal Study of Safety and Performance.","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Dotspace Inc.","sponsor_slug":"dotspace-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07490496","publication_url":"https://clinicaltrials.gov/study/NCT07490496","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of CPL-01 in the Management of Postoperative Pain After Unilateral Distal First Metatarsal Bunionectomy With Osteotomy","has_exemption":false,"start_date":"2026-07-01","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"Cali Pharmaceuticals LLC","sponsor_slug":"cali-pharmaceuticals-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07619521","publication_url":"https://clinicaltrials.gov/study/NCT07619521","title":"Phase I/II Study of the MEK Inhibitor Selumetinib Plus DS-8201a in KRAS-Mutant, HER2-Expressing Pancreatic Ductal Adenocarcinoma","has_exemption":false,"start_date":"2026-09-08","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07747883","publication_url":"https://clinicaltrials.gov/study/NCT07747883","title":"First-in-Human Use of the IV-X Medical Intravascular Lithotripsy System in Patients With Peripheral Artery Disease","has_exemption":false,"start_date":"2026-09-14","completion_date":"2026-10-30","has_results":false,"results_due":false,"sponsor_name":"IVX Medical","sponsor_slug":"ivx-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT00508443","publication_url":"https://clinicaltrials.gov/study/NCT00508443","title":"Phase I/II Evaluation of a Novel CT-On-Rails or Trilogy Stereotactic Spine Radiotherapy System (SSRS) for the Treatment of Metastatic Spine Disease","has_exemption":false,"start_date":"2002-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT00501826","publication_url":"https://clinicaltrials.gov/study/NCT00501826","title":"Phase II Study of Hyper-CVAD Plus Nelarabine in Previously Untreated T-ALL and Lymphoblastic Lymphoma","has_exemption":false,"start_date":"2007-07-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01189786","publication_url":"https://clinicaltrials.gov/study/NCT01189786","title":"Ex Vivo T-Cell Depletion of Mobilized Peripheral Blood Stem Cells Via CD34-Selection (EXCESS)","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Baylor College of Medicine","sponsor_slug":"baylor-college-of-medicine","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01223248","publication_url":"https://clinicaltrials.gov/study/NCT01223248","title":"A Phase III Randomized Study Comparing Two Dosing Schedules for Hypofractionated Image-Guided Radiation Therapy in Patients With Metastatic Cancer","has_exemption":false,"start_date":"2010-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01220583","publication_url":"https://clinicaltrials.gov/study/NCT01220583","title":"A Randomized Phase II/Phase III Study of Adjuvant Concurrent Radiation and Chemotherapy Versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors","has_exemption":false,"start_date":"2011-01-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Radiation Therapy Oncology Group","sponsor_slug":"radiation-therapy-oncology-group","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02178410","publication_url":"https://clinicaltrials.gov/study/NCT02178410","title":"Vitamin D and Omega-3 Trial (VITAL Rhythm Study)","has_exemption":false,"start_date":"2012-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT01881503","publication_url":"https://clinicaltrials.gov/study/NCT01881503","title":"Expanded Access Protocol for the Treatment Use of HBOC-201","has_exemption":false,"start_date":"2013-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Englewood Hospital and Medical Center","sponsor_slug":"englewood-hospital-and-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02269150","publication_url":"https://clinicaltrials.gov/study/NCT02269150","title":"A Randomized Controlled Trial of Autologous Fecal Microbiota Transplantation (Auto-FMT) for Prophylaxis of Clostridium Difficile Infection in Recipients of Allogeneic Hematopoietic Stem Cell Transplantation","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02323867","publication_url":"https://clinicaltrials.gov/study/NCT02323867","title":"UNRELATED AND PARTIALLY MATCHED RELATED DONOR PERIPHERAL STEM CELL TRANSPLANTATION WITH Alpha/Beta T CELL AND B CELL DEPLETION FOR PATIENTS WITH HEMATOLOGIC MALIGNANCIES","has_exemption":false,"start_date":"2014-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital of Philadelphia","sponsor_slug":"childrens-hospital-of-philadelphia","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03119584","publication_url":"https://clinicaltrials.gov/study/NCT03119584","title":"Efficacy of Linaclotide in Type II Diabetics With Chronic Constipation: A Randomized, Double-Blind, Placebo-Controlled, Cross-Over Trial","has_exemption":false,"start_date":"2015-09-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Texas Tech University Health Sciences Center, El Paso","sponsor_slug":"texas-tech-university-health-sciences-center-el-paso","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02570542","publication_url":"https://clinicaltrials.gov/study/NCT02570542","title":"A Multi-center Randomized Phase II Study of the Impact of CD34+ Cell Dose on Absolute Lymphocyte Count Following High-Dose Therapy and Autologous Stem Cell Transplantation for Relapsed and Refractory Diffuse Large B-cell Lymphoma (DLBCL)","has_exemption":false,"start_date":"2015-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02725060","publication_url":"https://clinicaltrials.gov/study/NCT02725060","title":"Autoimmune Basis for Postural Tachycardia Syndrome","has_exemption":false,"start_date":"2016-02-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Vanderbilt University Medical Center","sponsor_slug":"vanderbilt-university-medical-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02716116","publication_url":"https://clinicaltrials.gov/study/NCT02716116","title":"A Phase 1/2 Study of the Safety, Pharmacokinetics, and Anti-Tumor Activity of the Oral EGFR/HER2 Inhibitor TAK-788 (AP32788) in Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2016-06-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02923570","publication_url":"https://clinicaltrials.gov/study/NCT02923570","title":"A Phase II Randomized Study of Proton Versus Photon Beam Radiotherapy in the Treatment of Unilateral Head and Neck Cancer","has_exemption":false,"start_date":"2016-10-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02932280","publication_url":"https://clinicaltrials.gov/study/NCT02932280","title":"A Phase I/II Study of Neratinib in Pediatric Patients With Relapsed or Refractory Solid Tumors","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT02921022","publication_url":"https://clinicaltrials.gov/study/NCT02921022","title":"Pilot Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma","has_exemption":false,"start_date":"2016-10-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":true,"days_late":null},{"registry_id":"NCT03141684","publication_url":"https://clinicaltrials.gov/study/NCT03141684","title":"A Phase 2 Study of Anti-PD-L1 Antibody (Atezolizumab) in Alveolar Soft Part Sarcoma","has_exemption":false,"start_date":"2017-04-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03122717","publication_url":"https://clinicaltrials.gov/study/NCT03122717","title":"A Phase 1/2 Study of Osimertinib in Combination With Gefitinib in EGFR Inhibitor naïve Advanced EGFR Mutant Lung Cancer","has_exemption":false,"start_date":"2017-05-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Dana-Farber Cancer Institute","sponsor_slug":"dana-farber-cancer-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03168659","publication_url":"https://clinicaltrials.gov/study/NCT03168659","title":"Post-Approval Study of the HeartLight Endoscopic Ablation System for the Treatment of Atrial Fibrillation","has_exemption":false,"start_date":"2017-06-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"CardioFocus","sponsor_slug":"cardiofocus","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03004287","publication_url":"https://clinicaltrials.gov/study/NCT03004287","title":"2015-12: A Phase II Study Exploring the Use of Early and Late Consolidation/Maintenance With Anti-CD38 (Protein) Monoclonal Antibody to Improve Progression Free Survival in Patients With Newly Diagnosed Multiple Myeloma","has_exemption":false,"start_date":"2017-07-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arkansas","sponsor_slug":"university-of-arkansas","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03178552","publication_url":"https://clinicaltrials.gov/study/NCT03178552","title":"A Phase II/III Multicenter Study Evaluating the Efficacy and Safety of Multiple Targeted Therapies as Treatments for Patients With Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) Harboring Actionable Somatic Mutations Detected in Blood (B-FAST: Blood-First Assay Screening Trial)","has_exemption":false,"start_date":"2017-09-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03315910","publication_url":"https://clinicaltrials.gov/study/NCT03315910","title":"Implementing Tobacco Treatment in Low Dose CT Lung Cancer Screening Sites","has_exemption":false,"start_date":"2017-10-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03323463","publication_url":"https://clinicaltrials.gov/study/NCT03323463","title":"A Prospective Single Arm Non-inferiority Trial of Major Radiation Dose De-Escalation Concurrent With Chemotherapy for Human Papilloma Virus Associated Oropharyngeal Carcinoma (Major De-escalation to 30Gy for Select Human Papillomavirus Associated Oropharyngeal Carcinoma)","has_exemption":false,"start_date":"2017-10-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03244384","publication_url":"https://clinicaltrials.gov/study/NCT03244384","title":"Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation","has_exemption":false,"start_date":"2017-11-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03386500","publication_url":"https://clinicaltrials.gov/study/NCT03386500","title":"A Phase 1/2 Trial for Patients With Newly Diagnosed Anal Cancer Treated With Concurrent Radiation Therapy, 5FU, Mitomycin and BMX-001","has_exemption":false,"start_date":"2017-11-28","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03315026","publication_url":"https://clinicaltrials.gov/study/NCT03315026","title":"Phase II Study of Interleukin 6 Blockade With Siltuximab to Decrease Symptom Burden in Patients Age 60-75 Undergoing Autologous Stem Cell Transplantation for Multiple Myeloma and AL Amyloidosis","has_exemption":false,"start_date":"2017-12-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03436485","publication_url":"https://clinicaltrials.gov/study/NCT03436485","title":"Safety and Pharmacokinetics of ODM-208 in Patients With Metastatic Castration-resistant Prostate Cancer","has_exemption":false,"start_date":"2018-03-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Orion Corporation, Orion Pharma","sponsor_slug":"orion-corporation-orion-pharma","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03355976","publication_url":"https://clinicaltrials.gov/study/NCT03355976","title":"BrUOG 354: A Phase II Randomized Trial of Nivolumab +/- Ipilimumab for Ovarian and Extra-renal Clear Cell Carcinomas","has_exemption":false,"start_date":"2018-04-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03090165","publication_url":"https://clinicaltrials.gov/study/NCT03090165","title":"A Phase I/II, Single Arm, Non-randomized Study of Ribociclib (LEE011), a CDK 4/6 Inhibitor, in Combination With Bicalutamide, an Androgen Receptor (AR) Inhibitor, in Advanced AR+ Triple-negative Breast Cancer: Big Ten Cancer Research Consortium BRE15-024","has_exemption":false,"start_date":"2018-05-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Kari Wisinski","sponsor_slug":"kari-wisinski","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03487185","publication_url":"https://clinicaltrials.gov/study/NCT03487185","title":"A Randomized Trial of Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy","has_exemption":false,"start_date":"2018-08-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The George Washington University Biostatistics Center","sponsor_slug":"the-george-washington-university-biostatistics-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03705234","publication_url":"https://clinicaltrials.gov/study/NCT03705234","title":"HPS-4/TIMI 65/ORION-4: A Double-blind Randomized Placebo-controlled Trial Assessing the Effects of Inclisiran on Clinical Outcomes Among People With Atherosclerotic Cardiovascular Disease","has_exemption":false,"start_date":"2018-10-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Oxford","sponsor_slug":"university-of-oxford","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03607890","publication_url":"https://clinicaltrials.gov/study/NCT03607890","title":"Phase 2 Study of Nivolumab and Relatlimab in Advanced Mismatch Repair Deficient Cancers Resistant to Prior PD-(L)1 Inhibitor","has_exemption":false,"start_date":"2018-11-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins","sponsor_slug":"sidney-kimmel-comprehensive-cancer-center-at-johns-hopkins","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03183895","publication_url":"https://clinicaltrials.gov/study/NCT03183895","title":"Safety and Performance Evaluation of the AccuCinch® Ventricular Restoration System for the Treatment of Heart Failure With or Without Functional Mitral Regurgitation Due to Dilated Ischemic or Non-Ischemic Cardiomyopathy - The CorCinch-EU Study","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ancora Heart, Inc.","sponsor_slug":"ancora-heart-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04258462","publication_url":"https://clinicaltrials.gov/study/NCT04258462","title":"Hyperpolarized 13C Pyruvate Metabolic MRI to Predict Renal Tumor Aggressiveness","has_exemption":false,"start_date":"2019-01-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Zhen Wang, MD","sponsor_slug":"zhen-wang-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03513939","publication_url":"https://clinicaltrials.gov/study/NCT03513939","title":"A Safety, Tolerability and Efficacy Study of Sernova's Cell Pouch™ for Clinical Islet Transplantation","has_exemption":false,"start_date":"2019-02-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sernova Biotherapeutics Inc.","sponsor_slug":"sernova-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03184454","publication_url":"https://clinicaltrials.gov/study/NCT03184454","title":"Combined Cortical and Subcortical Recording and Stimulation as a Circuit-Oriented Treatment for Obsessive-Compulsive Disorder","has_exemption":false,"start_date":"2019-03-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Massachusetts General Hospital","sponsor_slug":"massachusetts-general-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03968822","publication_url":"https://clinicaltrials.gov/study/NCT03968822","title":"The Use of Intralipid® 20% Solution to Reverse the Anesthetic Effect of Local Anesthetics: a Proof of Concept Study in Volunteers","has_exemption":false,"start_date":"2019-07-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hospital for Special Surgery, New York","sponsor_slug":"hospital-for-special-surgery-new-york","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03994796","publication_url":"https://clinicaltrials.gov/study/NCT03994796","title":"Genomically-Guided Treatment Trial in Brain Metastases","has_exemption":false,"start_date":"2019-10-17","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Alliance for Clinical Trials in Oncology","sponsor_slug":"alliance-for-clinical-trials-in-oncology","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04143516","publication_url":"https://clinicaltrials.gov/study/NCT04143516","title":"Clinical Trial Optimizing Tumor Ablation for Liver Metastases: Rapid Tissue Analysis Allowing for Immediate Retreatment; Metabolic Imaging Biomarker Validation; and Predictive Genetic Signatures","has_exemption":false,"start_date":"2019-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04148430","publication_url":"https://clinicaltrials.gov/study/NCT04148430","title":"A Phase II Study of IL-1 Receptor Antagonist Anakinra to Prevent Severe Neurotoxicity and Cytokine Release Syndrome in Patients Receiving CD19-Specific Chimeric Antigen Receptor (CAR) T Cells","has_exemption":false,"start_date":"2019-10-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04047628","publication_url":"https://clinicaltrials.gov/study/NCT04047628","title":"A Multicenter Randomized Controlled Trial of Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Treatment-Resistant Relapsing Multiple Sclerosis (ITN077AI)","has_exemption":false,"start_date":"2019-12-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Institute of Allergy and Infectious Diseases (NIAID)","sponsor_slug":"national-institute-of-allergy-and-infectious-diseases-niaid","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04129502","publication_url":"https://clinicaltrials.gov/study/NCT04129502","title":"A Randomized Phase 3 Multicenter Open-Label Study to Compare the Efficacy of TAK-788 as First-Line Treatment Versus Platinum-Based Chemotherapy in Patients With Non-Small Cell Lung Cancer With EGFR Exon 20 Insertion Mutations","has_exemption":false,"start_date":"2020-01-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Takeda","sponsor_slug":"takeda","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04218617","publication_url":"https://clinicaltrials.gov/study/NCT04218617","title":"Single- vs. Two-Fraction Spine Stereotactic Radiosurgery for the Treatment of Vertebral Metastases","has_exemption":false,"start_date":"2020-02-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Case Comprehensive Cancer Center","sponsor_slug":"case-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04088396","publication_url":"https://clinicaltrials.gov/study/NCT04088396","title":"Open-Label, Randomized Study With a Tocilizumab Reference Arm to Evaluate Safety, Efficacy and Pharmacokinetics of Baricitinib in Children From 1 to Less Than 18 Years of Age With Systemic Juvenile Idiopathic Arthritis.","has_exemption":false,"start_date":"2020-02-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262466","publication_url":"https://clinicaltrials.gov/study/NCT04262466","title":"Phase 1/2 Study of IMC-F106C in Advance PRAME-Positive Cancers","has_exemption":false,"start_date":"2020-02-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Immunocore Ltd","sponsor_slug":"immunocore-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04115514","publication_url":"https://clinicaltrials.gov/study/NCT04115514","title":"PHASE II RANDOMIZED, INTERVENTION VERSUS NON- INTERVENTION, MULTI- CENTER STUDY OF THE EFFECTS OF THYROID HORMONE (T3) ON SAFETY/TOLERABILITY AND OXYGENATION IN SUBJECTS WITH ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)","has_exemption":false,"start_date":"2020-03-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Minnesota","sponsor_slug":"university-of-minnesota","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04291105","publication_url":"https://clinicaltrials.gov/study/NCT04291105","title":"Phase 2 Trial of Voyager VI (Vesicular Stomatitis Virus Expressing NIS and Human Interferon Beta, VV1), in Combination With Cemiplimab in Patients With Select Solid Tumors","has_exemption":false,"start_date":"2020-04-24","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Vyriad, Inc.","sponsor_slug":"vyriad-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03992430","publication_url":"https://clinicaltrials.gov/study/NCT03992430","title":"A Randomized, Double-Blind, Dose Finding and Comparison Study of the Safety and Efficacy of High Doses of Eteplirsen, Preceded by an Open-label Dose Escalation, in Patients With Duchenne Muscular Dystrophy With Deletion Mutations Amenable to Exon 51 Skipping","has_exemption":false,"start_date":"2020-07-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sarepta Therapeutics, Inc.","sponsor_slug":"sarepta-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT03832361","publication_url":"https://clinicaltrials.gov/study/NCT03832361","title":"A Phase II Evaluation of the Safety and Efficacy of Mirvetuximab Soravtansine (IMGN853) in Women With Folate Receptor-α Positive Persistent or Recurrent Endometrial Cancer","has_exemption":false,"start_date":"2020-07-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Alessandro Santin","sponsor_slug":"alessandro-santin","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04299191","publication_url":"https://clinicaltrials.gov/study/NCT04299191","title":"Study of LAM561 Acid in Pediatric Patients With Malignant Glioma and Other Advanced Solid Tumors","has_exemption":false,"start_date":"2020-09-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Laminar Pharmaceuticals","sponsor_slug":"laminar-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04262141","publication_url":"https://clinicaltrials.gov/study/NCT04262141","title":"Investigator-Initiated Trial of the LSD1 Inhibitor IMG-7289 for the Treatment of Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) That Have Failed at Least One Standard Therapy","has_exemption":false,"start_date":"2020-10-02","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Terrence J Bradley, MD","sponsor_slug":"terrence-j-bradley-md","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04623801","publication_url":"https://clinicaltrials.gov/study/NCT04623801","title":"Pilot Study to Evaluate the Safety and Efficacy of Percutaneous Laser Ablation of Thyroid Papillary Microcarcinoma","has_exemption":false,"start_date":"2020-10-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04715958","publication_url":"https://clinicaltrials.gov/study/NCT04715958","title":"Monitoring Neoadjuvant Chemotherapy of Breast Cancer Using 3D Subharmonic Aided Pressure Estimation","has_exemption":false,"start_date":"2020-12-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Kibo Nam","sponsor_slug":"kibo-nam","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04746235","publication_url":"https://clinicaltrials.gov/study/NCT04746235","title":"A Phase 2 Study of Venetoclax in Combination With ASTX727 in Patients With Relapsed/Refractory Acute Myeloid Leukemia, and Newly Diagnosed Elderly Patients With AML Who Are Not Candidates for Intensive Chemotherapy","has_exemption":false,"start_date":"2021-02-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"M.D. Anderson Cancer Center","sponsor_slug":"md-anderson-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04103476","publication_url":"https://clinicaltrials.gov/study/NCT04103476","title":"Atherosclerosis Intervention With Novel Tissue Selective Estrogen Complex Therapy","has_exemption":false,"start_date":"2021-04-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Southern California","sponsor_slug":"university-of-southern-california","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04763200","publication_url":"https://clinicaltrials.gov/study/NCT04763200","title":"Impella®-Supported PCI in High-Risk Patients With Complex Coronary Artery Disease and Reduced Left Ventricular Function: The PROTECT IV Trial","has_exemption":false,"start_date":"2021-04-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Abiomed Inc.","sponsor_slug":"abiomed-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04947735","publication_url":"https://clinicaltrials.gov/study/NCT04947735","title":"Control of Myopia Using Peripheral Diffusion Lenses: Efficacy and Safety Study Extension","has_exemption":false,"start_date":"2021-07-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"SightGlass Vision, Inc.","sponsor_slug":"sightglass-vision-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04791839","publication_url":"https://clinicaltrials.gov/study/NCT04791839","title":"A Pilot Study to Evaluate the Safety and Efficacy of Zimberelimab (AB122) in Combination With Domvanalimab (AB154) and Etrumadenant (AB928) in Patients With Previously Treated Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2021-08-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04965493","publication_url":"https://clinicaltrials.gov/study/NCT04965493","title":"A Phase 3 Open-Label, Randomized Study of Fixed Duration Pirtobrutinib (LOXO-305) Plus Venetoclax and Rituximab Versus Venetoclax and Rituximab in Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (BRUIN CLL-322)","has_exemption":false,"start_date":"2021-09-20","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Loxo Oncology, Inc.","sponsor_slug":"loxo-oncology-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04933903","publication_url":"https://clinicaltrials.gov/study/NCT04933903","title":"BrUOG 397: NEO Rad (LOW): Neoadjuvant Low Dose Stereotactic Body Radiotherapy, Ipilimumab and Nivolumab for Patients With Resectable Stage IB - III Non-Small Cell Lung Cancer","has_exemption":false,"start_date":"2021-10-05","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brown University","sponsor_slug":"brown-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05343598","publication_url":"https://clinicaltrials.gov/study/NCT05343598","title":"Empirical Validation of a Cerebellar-cortical Hallucination Circuit","has_exemption":false,"start_date":"2021-10-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05120934","publication_url":"https://clinicaltrials.gov/study/NCT05120934","title":"A Randomized, Double-blind, Placebo Controlled, Dose Escalation Pilot Study Evaluating the Efficacy of Two Doses of Duloxetine and Amitriptyline in Interstitial Lung Disease-related Cough","has_exemption":false,"start_date":"2021-11-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mayo Clinic","sponsor_slug":"mayo-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05102929","publication_url":"https://clinicaltrials.gov/study/NCT05102929","title":"Enhancing Prefrontal Oscillatory Activity and Working Memory Performance With Noninvasive Brain Stimulation in Early-course Schizophrenia","has_exemption":false,"start_date":"2021-11-05","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Fabio Ferrarelli","sponsor_slug":"fabio-ferrarelli","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05117827","publication_url":"https://clinicaltrials.gov/study/NCT05117827","title":"Pediatric Powered Wheelchair Standing Devices: An Exploratory Study","has_exemption":false,"start_date":"2021-11-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Grand Valley State University","sponsor_slug":"grand-valley-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05119179","publication_url":"https://clinicaltrials.gov/study/NCT05119179","title":"Pharmacogenetics of the Response to GLP-1 in Mexican-Americans With Prediabetes","has_exemption":false,"start_date":"2021-11-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Texas Health Science Center, Houston","sponsor_slug":"the-university-of-texas-health-science-center-houston","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05172726","publication_url":"https://clinicaltrials.gov/study/NCT05172726","title":"A Phase 3 Study of Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects","has_exemption":false,"start_date":"2021-12-02","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Organon and Co","sponsor_slug":"organon-and-co","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407636","publication_url":"https://clinicaltrials.gov/study/NCT05407636","title":"A Randomized, Partially Masked, Controlled, Phase 3 Clinical Study to Evaluate the Efficacy and Safety of RGX-314 Gene Therapy in Participants With nAMD","has_exemption":false,"start_date":"2022-01-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"AbbVie","sponsor_slug":"abbvie","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05134012","publication_url":"https://clinicaltrials.gov/study/NCT05134012","title":"A Phase 3, Multicenter, Open Label Study to Confirm the Diagnostic Potential of Intravenously Administered [15-O]-H2O to Identify Coronary Artery Disease During Pharmacological Stress and Resting Conditions Using PET Imaging (RAPID-WATER-FLOW)","has_exemption":false,"start_date":"2022-05-08","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"MedTrace Pharma A/S","sponsor_slug":"medtrace-pharma-as","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05365646","publication_url":"https://clinicaltrials.gov/study/NCT05365646","title":"Fall Risk Assessment and Speech Intelligibility Enhancement Using In-ear Device","has_exemption":false,"start_date":"2022-05-23","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Stanford University","sponsor_slug":"stanford-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05405595","publication_url":"https://clinicaltrials.gov/study/NCT05405595","title":"A Phase 1b/2, Open-Label, Dose Escalation and Expansion Study of ADG126 in Combination With Pembrolizumab (Anti PD-1 Antibody) in Patients With Advanced/Metastatic Solid Tumors","has_exemption":false,"start_date":"2022-06-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Adagene Inc","sponsor_slug":"adagene-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05000021","publication_url":"https://clinicaltrials.gov/study/NCT05000021","title":"Reducing Diabetes Distress Using Cognitive Behavioral Therapy in Young Adults With Type 1 Diabetes","has_exemption":false,"start_date":"2022-06-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Albert Einstein College of Medicine","sponsor_slug":"albert-einstein-college-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05139277","publication_url":"https://clinicaltrials.gov/study/NCT05139277","title":"Clinical Investigation to Evaluate the CONVIVO System for Discrimination of Normal From Abnormal Tissue During Brain Tumor Resection","has_exemption":false,"start_date":"2022-06-28","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Dartmouth-Hitchcock Medical Center","sponsor_slug":"dartmouth-hitchcock-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05042102","publication_url":"https://clinicaltrials.gov/study/NCT05042102","title":"The Combination of Donepezil and Cognitive Training for Treating Alcohol Use Disorder","has_exemption":false,"start_date":"2022-08-08","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"VA Connecticut Healthcare System","sponsor_slug":"va-connecticut-healthcare-system","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05336812","publication_url":"https://clinicaltrials.gov/study/NCT05336812","title":"Prospective Randomized Phase II Study of Acalabrutinib + Obinutuzumab or Venetoclax in Previously Untreated CLL","has_exemption":false,"start_date":"2022-09-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05584826","publication_url":"https://clinicaltrials.gov/study/NCT05584826","title":"MDMA-assisted Therapy for Adjustment Disorder (AD) in Dyads of Patients With Cancer and a Concerned Significant Other","has_exemption":false,"start_date":"2022-10-06","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sunstone Medical","sponsor_slug":"sunstone-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04991025","publication_url":"https://clinicaltrials.gov/study/NCT04991025","title":"Phase 2 Trial of Neoadjuvant Nivolumab + Platinum-based Chemotherapy + Certolizumab in Patients With Resectable Stages II-III Lung Cancers","has_exemption":false,"start_date":"2022-10-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05461157","publication_url":"https://clinicaltrials.gov/study/NCT05461157","title":"The Application of Preoperative Silicone Ointment and Its Effect on Wound Healing","has_exemption":false,"start_date":"2022-11-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Yale University","sponsor_slug":"yale-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05407324","publication_url":"https://clinicaltrials.gov/study/NCT05407324","title":"A Phase 2, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study Evaluating Safety and Efficacy of CORT113176 (Dazucorilant) in Patients With Amyotrophic Lateral Sclerosis (DAZALS)","has_exemption":false,"start_date":"2022-11-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Corcept Therapeutics","sponsor_slug":"corcept-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05554172","publication_url":"https://clinicaltrials.gov/study/NCT05554172","title":"Efficacy of Non-invasive Vagus Nerve Stimulation for Treatment of Low Weight Eating Disorders","has_exemption":false,"start_date":"2022-12-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Icahn School of Medicine at Mount Sinai","sponsor_slug":"icahn-school-of-medicine-at-mount-sinai","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05648500","publication_url":"https://clinicaltrials.gov/study/NCT05648500","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-Severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2022-12-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05030545","publication_url":"https://clinicaltrials.gov/study/NCT05030545","title":"Cardiovascular Manifestations of MR Activation in Primary Aldosteronism: Pilot Clinical Study","has_exemption":false,"start_date":"2022-12-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Brigham and Women's Hospital","sponsor_slug":"brigham-and-womens-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07546929","publication_url":"https://clinicaltrials.gov/study/NCT07546929","title":"HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes","has_exemption":false,"start_date":"2023-02-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Housey Healthcare ULC","sponsor_slug":"housey-healthcare-ulc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05795465","publication_url":"https://clinicaltrials.gov/study/NCT05795465","title":"A Phase 2, Two-Part Study to Evaluate the Safety and Tolerability of GEn-1124 in Subjects With Acute Respiratory Distress Syndrome (ARDS)","has_exemption":false,"start_date":"2023-04-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"GEn1E Lifesciences","sponsor_slug":"gen1e-lifesciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05640271","publication_url":"https://clinicaltrials.gov/study/NCT05640271","title":"Low-Dose Tocilizumab for Acute Chest Syndrome in Sickle Cell Disease","has_exemption":false,"start_date":"2023-04-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Chicago","sponsor_slug":"university-of-chicago","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05757869","publication_url":"https://clinicaltrials.gov/study/NCT05757869","title":"A Phase 3, Randomized, Double-Blind, Double-Dummy, Parallel Group, Active-Controlled Study to Evaluate the Efficacy and Safety of Milvexian, an Oral Factor XIa Inhibitor, Versus Apixaban in Participants With Atrial Fibrillation","has_exemption":false,"start_date":"2023-04-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Janssen Research & Development, LLC","sponsor_slug":"janssen-research-development-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05716100","publication_url":"https://clinicaltrials.gov/study/NCT05716100","title":"A Randomized, Double-blind, Placebo-Controlled, Multicenter Phase 3 Study to Evaluate the Safety, Tolerability, and Efficacy of XEN1101 as Adjunctive Therapy in Focal-Onset Seizures","has_exemption":false,"start_date":"2023-05-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Xenon Pharmaceuticals Inc.","sponsor_slug":"xenon-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804084","publication_url":"https://clinicaltrials.gov/study/NCT05804084","title":"Patient-centered and Neurocognitive Outcomes With Acetazolamide for Sleep Apnea","has_exemption":false,"start_date":"2023-05-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05672576","publication_url":"https://clinicaltrials.gov/study/NCT05672576","title":"A Phase 3, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy, Safety, and Tolerability of Cenerimod in Adult Subjects With Moderate-to-severe Systemic Lupus Erythematosus (SLE) on Top of Background Therapy","has_exemption":false,"start_date":"2023-06-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Viatris Innovation GmbH","sponsor_slug":"viatris-innovation-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05741060","publication_url":"https://clinicaltrials.gov/study/NCT05741060","title":"Arterial Stiffness, Cognition and Equol","has_exemption":false,"start_date":"2023-06-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Akira Sekikawa","sponsor_slug":"akira-sekikawa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05669833","publication_url":"https://clinicaltrials.gov/study/NCT05669833","title":"Guselkumab vs Golimumab in PsA TNF Inadequate Responder Patients: a Pragmatic Trial (EVOLUTION)","has_exemption":false,"start_date":"2023-07-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Pennsylvania","sponsor_slug":"university-of-pennsylvania","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05852691","publication_url":"https://clinicaltrials.gov/study/NCT05852691","title":"A Phase II, Multicenter, Randomized, Double-Blind Study of Tobemstomig/RO7247669 Combined With Nab-Paclitaxel Compared With Pembrolizumab Combined With Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer","has_exemption":false,"start_date":"2023-07-18","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hoffmann-La Roche","sponsor_slug":"hoffmann-la-roche","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06052267","publication_url":"https://clinicaltrials.gov/study/NCT06052267","title":"A Randomized, Double-Blind, Multicenter, Active-Controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Fixed-Dose Combination on Severe Asthma Exacerbations in Patients With Asthma","has_exemption":false,"start_date":"2023-08-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Teva Branded Pharmaceutical Products R&D LLC","sponsor_slug":"teva-branded-pharmaceutical-products-rd-llc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05734560","publication_url":"https://clinicaltrials.gov/study/NCT05734560","title":"Delivery of D2C7-IT and 2141-V11 Combination Immunotherapy in Residual Disease for Adult Patients With Newly Diagnosed MGMT Unmethylated Glioblastoma and Perilymphatic Subcutaneous Injections of 2141-V11","has_exemption":false,"start_date":"2023-09-06","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Darell Bigner","sponsor_slug":"darell-bigner","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06057922","publication_url":"https://clinicaltrials.gov/study/NCT06057922","title":"A Multicenter, Open-Label, Phase 1/2 Study to Evaluate the Safety, Efficacy, and Pharmacokinetics of YL201 in Patients With Selected Advanced Solid Tumors","has_exemption":false,"start_date":"2023-09-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"MediLink Therapeutics (Suzhou) Co., Ltd.","sponsor_slug":"medilink-therapeutics-suzhou-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05417165","publication_url":"https://clinicaltrials.gov/study/NCT05417165","title":"Phase II Comparative Study of Anti-Pneumococcal Vaccine Strategy in Patients With Chronic Lymphocytic Leukemia","has_exemption":false,"start_date":"2023-09-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Seema Bhat","sponsor_slug":"seema-bhat","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05369520","publication_url":"https://clinicaltrials.gov/study/NCT05369520","title":"Non-invasive Spinal Cord Stimulation for Recovery of Autonomic Function After Spinal Cord Injury: Moving From Mechanisms to Clinical Practice","has_exemption":false,"start_date":"2023-10-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of British Columbia","sponsor_slug":"university-of-british-columbia","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05615649","publication_url":"https://clinicaltrials.gov/study/NCT05615649","title":"Expanded Indications in the Pediatric BONEBRIDGE Population","has_exemption":false,"start_date":"2023-10-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Med-El Corporation","sponsor_slug":"med-el-corporation","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05804669","publication_url":"https://clinicaltrials.gov/study/NCT05804669","title":"A Phase 1b/2a Open-label Multiple-ascending Dose Exploratory Study of CRN04894 in ACTH-dependent Cushing's Syndrome (Cushing's Disease or Ectopic ACTH Syndrome)","has_exemption":false,"start_date":"2023-10-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Crinetics Pharmaceuticals Inc.","sponsor_slug":"crinetics-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05318469","publication_url":"https://clinicaltrials.gov/study/NCT05318469","title":"A Phase I/II Study Evaluating the Safety and Efficacy of Ivermectin in Combination With Immune Checkpoint Inhibitor in Patients With Metastatic Triple Negative Breast Cancer","has_exemption":false,"start_date":"2023-10-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Yuan Yuan","sponsor_slug":"yuan-yuan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06083922","publication_url":"https://clinicaltrials.gov/study/NCT06083922","title":"A Phase II Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab for Patients With Monoclonal Gammopathy of Renal Significance (MGRS)","has_exemption":false,"start_date":"2023-10-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Memorial Sloan Kettering Cancer Center","sponsor_slug":"memorial-sloan-kettering-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05598333","publication_url":"https://clinicaltrials.gov/study/NCT05598333","title":"A Phase 2, Adaptive, Double-blinded, Placebo Controlled, Randomized, Multi-center Trial to Evaluate the Efficacy, Safety and Tolerability of Intracoronary Infusion of AB-1002 in Adult Subjects With New York Heart Association (NYHA) Class III Heart Failure and Non-ischemic Cardiomyopathy","has_exemption":false,"start_date":"2023-10-20","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"AskBio Inc","sponsor_slug":"askbio-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05715619","publication_url":"https://clinicaltrials.gov/study/NCT05715619","title":"A Phase 1/2a Double-Blind, Randomized, Placebo-Controlled Trial to Assess the Safety and Efficacy of Oral Administration of the Phage Cocktail, VRELysin™, In Healthy And VRE-Colonized Subjects","has_exemption":false,"start_date":"2023-10-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Intralytix, Inc.","sponsor_slug":"intralytix-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06016738","publication_url":"https://clinicaltrials.gov/study/NCT06016738","title":"A Phase 3 Randomized, Open-Label Study of OP-1250 Monotherapy vs Standard of Care for the Treatment of ER+, HER2- Advanced or Metastatic Breast Cancer Following Endocrine and CDK 4/6 Inhibitor Therapy (OPERA-01)","has_exemption":false,"start_date":"2023-11-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Olema Pharmaceuticals, Inc.","sponsor_slug":"olema-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05561114","publication_url":"https://clinicaltrials.gov/study/NCT05561114","title":"Paclitaxel Coated Balloon for the Treatment of Chronic bEnigN sTricture- Esophagus","has_exemption":false,"start_date":"2023-12-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"GIE Medical","sponsor_slug":"gie-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06223659","publication_url":"https://clinicaltrials.gov/study/NCT06223659","title":"Investigating the Use of EMLA Topical Cream for Patients Receiving Intra-Dermal Technetium 99 Injections for Lymphoscintigraphy for Cutaneous Cancers","has_exemption":false,"start_date":"2023-12-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Ohio State University Comprehensive Cancer Center","sponsor_slug":"ohio-state-university-comprehensive-cancer-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06077227","publication_url":"https://clinicaltrials.gov/study/NCT06077227","title":"Immersive Healing: The Therapeutic Potential of Virtual Reality in Phantom Limb Experience","has_exemption":false,"start_date":"2023-12-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Wake Forest University Health Sciences","sponsor_slug":"wake-forest-university-health-sciences","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05886036","publication_url":"https://clinicaltrials.gov/study/NCT05886036","title":"NORM: Nodular Lymphocyte-Predominant Hodgkin Lymphoma Patients Treated in a Randomized Phase 2 Trial With Either Rituximab or Mosunetuzumab","has_exemption":false,"start_date":"2024-01-23","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"National Cancer Institute (NCI)","sponsor_slug":"national-cancer-institute-nci","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05746572","publication_url":"https://clinicaltrials.gov/study/NCT05746572","title":"A Pilot Study of MDMA-Assisted Massed Exposure Therapy for PTSD (MDMA PE)","has_exemption":false,"start_date":"2024-02-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05787639","publication_url":"https://clinicaltrials.gov/study/NCT05787639","title":"Neoadjuvant Radiation and Evorpacept (ALX148) in Combination With Pembrolizumab In Patients With Previously Untreated Locally Advanced, Resectable, HPVOPC (Human Papilloma Virus Oropharynx Cancer)","has_exemption":false,"start_date":"2024-02-23","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, San Diego","sponsor_slug":"university-of-california-san-diego","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06477406","publication_url":"https://clinicaltrials.gov/study/NCT06477406","title":"Evaluating the Impact of a Novel Cannabinoid Product for Endometriosis","has_exemption":false,"start_date":"2024-02-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mclean Hospital","sponsor_slug":"mclean-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06335173","publication_url":"https://clinicaltrials.gov/study/NCT06335173","title":"A Phase 2 Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Intravenous Sabirnetug in Early Alzheimer's Disease","has_exemption":false,"start_date":"2024-02-29","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Acumen Pharmaceuticals","sponsor_slug":"acumen-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT04003506","publication_url":"https://clinicaltrials.gov/study/NCT04003506","title":"Comparing the Efficacy of Combining Periarticular Local Infiltration of Analgesia and Adductor Canal Block Using Liposomal Bupivacaine and Standard Bupivacaine in Total Knee Arthroplasty - A Prospective Randomized Controlled Trial","has_exemption":false,"start_date":"2024-03-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The University of Hong Kong","sponsor_slug":"the-university-of-hong-kong","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06195982","publication_url":"https://clinicaltrials.gov/study/NCT06195982","title":"Acute Effects of Ketones in Heart Failure With Reduced Ejection Fraction","has_exemption":false,"start_date":"2024-03-06","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06266338","publication_url":"https://clinicaltrials.gov/study/NCT06266338","title":"A Phase 2A, Prospective, Open Label, Single Institution Study of Pembrolizumab and Lenvatinib in Metastatic and Recurrent Cervix Cancer (LenPem Cervix)","has_exemption":false,"start_date":"2024-03-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Texas Southwestern Medical Center","sponsor_slug":"university-of-texas-southwestern-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06297603","publication_url":"https://clinicaltrials.gov/study/NCT06297603","title":"A Phase 3, Randomized, Multicenter, Double-Blind Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly Compared With Placebo in Adult Participants With Type 2 Diabetes, Moderate or Severe Renal Impairment With Inadequate Glycemic Control on Basal Insulin With or Without Metformin and/or SGLT2 Inhibitor","has_exemption":false,"start_date":"2024-03-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Eli Lilly and Company","sponsor_slug":"eli-lilly-and-company","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06050122","publication_url":"https://clinicaltrials.gov/study/NCT06050122","title":"A Multicenter, Randomized, Double Blind, Vehicle-controlled, Phase 3 Efficacy and Safety Study of Patidegib Gel 2% for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Gorlin Syndrome","has_exemption":false,"start_date":"2024-03-17","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Sol-Gel Technologies, Ltd.","sponsor_slug":"sol-gel-technologies-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06369298","publication_url":"https://clinicaltrials.gov/study/NCT06369298","title":"A Phase 2 Randomized, Double-blind, Placebo-controlled Study to Assess the Safety and Efficacy of JK07 in Adults With Chronic Heart Failure (RENEU-HF)","has_exemption":false,"start_date":"2024-03-28","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Salubris Biotherapeutics Inc","sponsor_slug":"salubris-biotherapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06273553","publication_url":"https://clinicaltrials.gov/study/NCT06273553","title":"An Open-Label, Phase 1/2 Study to Evaluate the Safety, Tolerability, Immunogenicity and Efficacy of RG002 Injection (an mRNA Therapeutic Vaccine) in Subjects With Human Papillomavirus (HPV) 16 or 18 Associated Cervical Intraepithelial Neoplasia Grade 2 or 3 (CIN2/3)","has_exemption":false,"start_date":"2024-03-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"RinuaGene Biotechnology Co., Ltd.","sponsor_slug":"rinuagene-biotechnology-co-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06179004","publication_url":"https://clinicaltrials.gov/study/NCT06179004","title":"Randomized Controlled Trial of Supraclavicular Bupivacaine Vs. Supraclavicular Liposomal Bupivacaine for Orthopedic Wrist Surgery","has_exemption":false,"start_date":"2024-04-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of North Carolina, Chapel Hill","sponsor_slug":"university-of-north-carolina-chapel-hill","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06125951","publication_url":"https://clinicaltrials.gov/study/NCT06125951","title":"A Phase 2b/3, Double-Blind, Placebo-Controlled, Parallel-Group, 36-Week, 2-Arm Trial With an Open-Label Extension Phase to Assess the Safety, Tolerability, and Efficacy of Xanamem® 10 mg Daily in Patients With Mild or Moderate Dementia Due to Alzheimer's Disease","has_exemption":false,"start_date":"2024-04-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Actinogen Medical","sponsor_slug":"actinogen-medical","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06240351","publication_url":"https://clinicaltrials.gov/study/NCT06240351","title":"A Pilot Study to Evaluate the Safety and Efficacy of Baricitinib in the Treatment of Frontal Fibrosing Alopecia (FFA)","has_exemption":false,"start_date":"2024-04-22","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Alabama at Birmingham","sponsor_slug":"university-of-alabama-at-birmingham","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06309966","publication_url":"https://clinicaltrials.gov/study/NCT06309966","title":"A Phase 2/3 Multicenter, Randomization, Double-Blind, Placebo-Controlled, Study to Evaluate the Efficacy, Safety and Tolerability of BHV-7000 in Subjects With Refractory Focal Onset Epilepsy","has_exemption":false,"start_date":"2024-05-13","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Biohaven Therapeutics Ltd.","sponsor_slug":"biohaven-therapeutics-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06136585","publication_url":"https://clinicaltrials.gov/study/NCT06136585","title":"Comparison of Efficacy of Sugammadex Versus Neostigmine in Reversing Neuromuscular Blocks in Patients Having Outpatient Endoscopic Retrograde Cholangiopancreatography (ERCP). A Randomized, Double-Blinded Trial","has_exemption":false,"start_date":"2024-06-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"The Cleveland Clinic","sponsor_slug":"the-cleveland-clinic","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06363877","publication_url":"https://clinicaltrials.gov/study/NCT06363877","title":"Wound Irrigation and Peritoneal Lavage With Diluted Aqueous Povidone-Iodine Compared to Saline to Decrease Surgical Site Infections","has_exemption":false,"start_date":"2024-06-03","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Loma Linda University","sponsor_slug":"loma-linda-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06463158","publication_url":"https://clinicaltrials.gov/study/NCT06463158","title":"A Phase I Clinical Trial Evaluating the Impact of the Family Room App on Caregiver Well-being, Satisfaction, and Engagement in the Intensive Care Unit","has_exemption":false,"start_date":"2024-07-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Nebraska","sponsor_slug":"university-of-nebraska","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06340451","publication_url":"https://clinicaltrials.gov/study/NCT06340451","title":"A Multicenter, Randomized, Double-Blind, Sham-Controlled Study Assessing the Efficacy and Safety of Iovera®° System in Subjects With Upper Extremity Spasticity","has_exemption":false,"start_date":"2024-07-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Pacira Pharmaceuticals, Inc","sponsor_slug":"pacira-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06445023","publication_url":"https://clinicaltrials.gov/study/NCT06445023","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU1)","has_exemption":false,"start_date":"2024-07-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06455202","publication_url":"https://clinicaltrials.gov/study/NCT06455202","title":"A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Assess the Efficacy and Safety of Barzolvolimab in Patients With Chronic Spontaneous Urticaria Who Remain Symptomatic Despite H1 Antihistamine Treatment (EMBARQ-CSU2)","has_exemption":false,"start_date":"2024-07-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Celldex Therapeutics","sponsor_slug":"celldex-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06560307","publication_url":"https://clinicaltrials.gov/study/NCT06560307","title":"Examination of Programming with the Enterra® Therapy System in a Double-Blinded, Randomized, Prospective Study in the Treatment of Nausea and Vomiting Symptoms Using Gastric Electrical Stimulation","has_exemption":false,"start_date":"2024-07-25","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Enterra Medical, Inc.","sponsor_slug":"enterra-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06510816","publication_url":"https://clinicaltrials.gov/study/NCT06510816","title":"A Phase 3, Multicenter, Randomized, Parallel-Group, Double-Masked, 2-Arm, Sham Controlled Study of the Efficacy, Safety, and Tolerability of ANX007 (Vonaprument) Administered by Intravitreal Injection in Participants With Dry Age-Related Macular Degeneration With Geographic Atrophy","has_exemption":false,"start_date":"2024-07-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Annexon, Inc.","sponsor_slug":"annexon-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06129539","publication_url":"https://clinicaltrials.gov/study/NCT06129539","title":"LIBELULA™: An Open-label, Single-arm, Multi-center, Phase 3 Study on the Efficacy, Safety, and Pharmacokinetics of Debio 4326, a Triptorelin 12-month Formulation, in Pediatric Participants With Central Precocious Puberty","has_exemption":false,"start_date":"2024-07-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Debiopharm International SA","sponsor_slug":"debiopharm-international-sa","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06524375","publication_url":"https://clinicaltrials.gov/study/NCT06524375","title":"Phase II, Open-label, Prospective Single-arm, Multi-center Clinical Trial to Evaluate if Adding Venetoclax to Patients on Covalent BTKi For 1L CLL Can Achieve Deep Durable Remissions (by UMRD 10^-4) to Allow Off-treatment Period","has_exemption":false,"start_date":"2024-08-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Genentech, Inc.","sponsor_slug":"genentech-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06446752","publication_url":"https://clinicaltrials.gov/study/NCT06446752","title":"A Phase 3 Randomized, Observer-Blind, Placebo-Controlled Study to Assess Efficacy of Meningococcal Group B (rMenB+OMV NZ (Bexsero)) in Preventing Gonococcal Infection Among South African Cis-Gender Women","has_exemption":false,"start_date":"2024-08-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Washington","sponsor_slug":"university-of-washington","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05868330","publication_url":"https://clinicaltrials.gov/study/NCT05868330","title":"A Feasibility Randomized Control Comparison of Peripheral Interscalene Catheter to Liposomal Bupivacaine Single Injection for Interscalene Blocks Used in Pain Control for Total Shoulder Arthroplasties","has_exemption":false,"start_date":"2024-08-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Melinda Seering","sponsor_slug":"melinda-seering","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06055790","publication_url":"https://clinicaltrials.gov/study/NCT06055790","title":"Feasibility of 18F-Fluciclovine PET/CT to Identify Brain Metastasis","has_exemption":false,"start_date":"2024-09-10","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Arizona","sponsor_slug":"university-of-arizona","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06392932","publication_url":"https://clinicaltrials.gov/study/NCT06392932","title":"Esophageal Temperature Dynamics and Injury During Pulmonary Vein Isolation With Temperature Controlled Very-High-Power Short-Duration Lesions Using the Novel Q-DOT Micro Ablation Catheter","has_exemption":false,"start_date":"2024-10-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Cedars-Sinai Medical Center","sponsor_slug":"cedars-sinai-medical-center","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07163793","publication_url":"https://clinicaltrials.gov/study/NCT07163793","title":"A Pilot Study of Reduced Venetoclax Exposure in Patients With Acute Myeloid Leukemia in Complete Remission","has_exemption":false,"start_date":"2024-10-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Northwell Health","sponsor_slug":"northwell-health","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06553768","publication_url":"https://clinicaltrials.gov/study/NCT06553768","title":"Randomized Double-Blind Placebo-Controlled Phase 3 Study to Evaluate the Efficacy and Safety of Maralixibat in the Treatment of Participants With Cholestatic Pruritus","has_exemption":false,"start_date":"2024-10-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mirum Pharmaceuticals, Inc.","sponsor_slug":"mirum-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06597942","publication_url":"https://clinicaltrials.gov/study/NCT06597942","title":"Protocol for Maintaining and Improving Mental Status in Alzheimer's Disease (PROMIS-AD): a Pilot Study of Repetitive Transcranial Magnetic Stimulation of the Precuneus for Alzheimer&Amp;Amp;#39;s Disease","has_exemption":false,"start_date":"2024-10-17","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06375967","publication_url":"https://clinicaltrials.gov/study/NCT06375967","title":"Multicenter Study of EUS-guided Gallbladder Drainage vs Choledochoduodenostomy as First Line in Malignant Distal Obstruction in Palliative Patients (CARPEGIEM Trial): an Open-label, Randomized Controlled Clinical Trial","has_exemption":false,"start_date":"2024-10-18","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Hospital Universitari de Bellvitge","sponsor_slug":"hospital-universitari-de-bellvitge","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06614582","publication_url":"https://clinicaltrials.gov/study/NCT06614582","title":"Long-term Evaluation of Nasopharyngeal Airway in Hypotonia","has_exemption":false,"start_date":"2024-10-23","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06635863","publication_url":"https://clinicaltrials.gov/study/NCT06635863","title":"Immunosuppression Versus Medical Therapy for UN-explained Low Ejection Fraction and VT","has_exemption":false,"start_date":"2024-11-01","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Roderick Tung","sponsor_slug":"roderick-tung","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05893888","publication_url":"https://clinicaltrials.gov/study/NCT05893888","title":"A Phase 1/2/3 Multicenter Study Evaluating the PRV Platform of Localized Nanoengineered Therapies for Oral Cavity and Lung Cancers","has_exemption":false,"start_date":"2024-11-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Privo Technologies","sponsor_slug":"privo-technologies","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06719141","publication_url":"https://clinicaltrials.gov/study/NCT06719141","title":"A Phase 3, Randomized, Double-Blind, Placebo-Controlled, Multicenter Study to Investigate the Efficacy, Safety, and Tolerability of LP352 in the Treatment of Seizures in Children and Adults With Developmental and Epileptic Encephalopathies","has_exemption":false,"start_date":"2024-11-11","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Longboard Pharmaceuticals","sponsor_slug":"longboard-pharmaceuticals","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06422884","publication_url":"https://clinicaltrials.gov/study/NCT06422884","title":"A Phase 2, Multi-Center, Randomized, Double-Blind, Controlled Trial Evaluating the Safety and Efficacy of ENV-101 in Patients With Lung Fibrosis (WHISTLE-PF Trial)","has_exemption":false,"start_date":"2024-11-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Endeavor Biomedicines, Inc.","sponsor_slug":"endeavor-biomedicines-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06745466","publication_url":"https://clinicaltrials.gov/study/NCT06745466","title":"Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women","has_exemption":false,"start_date":"2024-11-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Delaware","sponsor_slug":"university-of-delaware","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06641635","publication_url":"https://clinicaltrials.gov/study/NCT06641635","title":"A Multicenter, Non-inferiority, Phase 3, Randomized Controlled Study of Moderated Hypofractionated Online Adaptive Radiotherapy for Cervical Cancer","has_exemption":false,"start_date":"2024-11-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Peking Union Medical College Hospital","sponsor_slug":"peking-union-medical-college-hospital","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05654103","publication_url":"https://clinicaltrials.gov/study/NCT05654103","title":"Randomized Controlled Trial Comparing endoAVF Versus surgAVF","has_exemption":false,"start_date":"2024-11-20","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of California, Los Angeles","sponsor_slug":"university-of-california-los-angeles","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06683742","publication_url":"https://clinicaltrials.gov/study/NCT06683742","title":"A 2-year Phase 3, Multicenter, Prospective, Randomized, Double-Masked, Parallel-Group Study of EYP-1901, a Tyrosine Kinase Inhibitor (TKI), Compared to Aflibercept in Subjects With Wet AMD","has_exemption":false,"start_date":"2024-11-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"EyePoint Pharmaceuticals, Inc.","sponsor_slug":"eyepoint-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06550024","publication_url":"https://clinicaltrials.gov/study/NCT06550024","title":"SakuraBead Used as Resorbable Embolic for Genicular Artery Embolization","has_exemption":false,"start_date":"2024-11-28","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"CrannMed","sponsor_slug":"crannmed","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06297200","publication_url":"https://clinicaltrials.gov/study/NCT06297200","title":"Investigations of Low-Intensity Focused Ultrasound Towards Treatment for the Complex Patient","has_exemption":false,"start_date":"2024-12-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Virginia Polytechnic Institute and State University","sponsor_slug":"virginia-polytechnic-institute-and-state-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06593522","publication_url":"https://clinicaltrials.gov/study/NCT06593522","title":"A Phase 2 Study Evaluating the Efficacy, Safety, Tolerability, and Pharmacokinetics of Anvumetostat in Subjects With Methylthioadenosine Phosphorylase (MTAP)-Deleted Previously Treated Advanced Non-Small Cell Lung Cancer (NSCLC)","has_exemption":false,"start_date":"2024-12-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Amgen","sponsor_slug":"amgen","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06585709","publication_url":"https://clinicaltrials.gov/study/NCT06585709","title":"The Development and Validation of Neural Targets in Opioid Use Disorder","has_exemption":false,"start_date":"2024-12-31","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Duke University","sponsor_slug":"duke-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06897358","publication_url":"https://clinicaltrials.gov/study/NCT06897358","title":"A Study to Assess Safety and Tolerability, and Explore Efficacy of Leniolisib for Immune Dysregulation in Common Variable Immunodeficiency (CVID)","has_exemption":false,"start_date":"2025-02-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Pharming Technologies B.V.","sponsor_slug":"pharming-technologies-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06841796","publication_url":"https://clinicaltrials.gov/study/NCT06841796","title":"The Young Men's Christian Association (YMCA) Healthy Lifestyle Program for Prediabetes","has_exemption":false,"start_date":"2025-02-17","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Young Men's Christian Association of the Blue Water Area","sponsor_slug":"young-mens-christian-association-of-the-blue-water-area","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06980805","publication_url":"https://clinicaltrials.gov/study/NCT06980805","title":"A Phase 2b, Randomized, Double-blind, Placebo-controlled Study to Assess the Safety, Tolerability, and Efficacy of IMVT-1402 in Participants With Active Subacute Cutaneous Lupus Erythematosus (SCLE) and/or Chronic Cutaneous Lupus Erythematosus (CCLE) With or Without Systemic Manifestations","has_exemption":false,"start_date":"2025-02-19","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Immunovant Sciences GmbH","sponsor_slug":"immunovant-sciences-gmbh","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06772597","publication_url":"https://clinicaltrials.gov/study/NCT06772597","title":"A Phase 2 Open-label Study of Setmelanotide in Patients With Prader-Willi Syndrome","has_exemption":false,"start_date":"2025-03-04","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Rhythm Pharmaceuticals, Inc.","sponsor_slug":"rhythm-pharmaceuticals-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06677151","publication_url":"https://clinicaltrials.gov/study/NCT06677151","title":"NPA-OSA Device Tolerability, Usability and Acclimation Clinical Study in Continuous Positive Airway Pressure (CPAP) Resistant Adult OSA Patients","has_exemption":false,"start_date":"2025-03-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06826196","publication_url":"https://clinicaltrials.gov/study/NCT06826196","title":"A Phase 1B/2A, Intraindividual Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of ALD-102 Solution for Intradermal Injection in Subjects With Alopecia Areata","has_exemption":false,"start_date":"2025-03-24","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Aldena Therapeutics","sponsor_slug":"aldena-therapeutics","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06620003","publication_url":"https://clinicaltrials.gov/study/NCT06620003","title":"A Phase 2, Randomized, Double-blind, Placebo-Controlled Trial to Evaluate Safety, Tolerability, and Immune Responses of an Investigational Monovalent Chimpanzee Adenoviral Vectored Marburg Virus Vaccine in Healthy Adults","has_exemption":false,"start_date":"2025-04-14","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Albert B. Sabin Vaccine Institute","sponsor_slug":"albert-b-sabin-vaccine-institute","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06752928","publication_url":"https://clinicaltrials.gov/study/NCT06752928","title":"A Randomized Controlled Trial Comparing Dexcom Continuous Glucose Monitoring to Point of Care Glucose Testing for the Management of Hospital and Post-Discharge Subjects With Type 1 Diabetes","has_exemption":false,"start_date":"2025-05-12","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Emory University","sponsor_slug":"emory-university","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT05485155","publication_url":"https://clinicaltrials.gov/study/NCT05485155","title":"An Open-Label Study of Zemaira (Alpha 1-Trypsin Inhibitor) in Subjects With Eosinophilic Esophagitis","has_exemption":false,"start_date":"2025-05-15","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Children's Hospital Medical Center, Cincinnati","sponsor_slug":"childrens-hospital-medical-center-cincinnati","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06880835","publication_url":"https://clinicaltrials.gov/study/NCT06880835","title":"INHALE-AIDEx: A Randomized Crossover Trial Evaluating the Effect of Inhaled Technosphere Insulin (Afrezza®) vs Rapid Acting Analogue Insulin on Exercise-Induced Hypoglycemia in Adults With Type 1 Diabetes Using Automated Insulin Delivery","has_exemption":false,"start_date":"2025-06-05","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Jaeb Center for Health Research","sponsor_slug":"jaeb-center-for-health-research","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT06698458","publication_url":"https://clinicaltrials.gov/study/NCT06698458","title":"A Study to Assess the Safety of Intratumoral Diffusing Alpha Radiation Emitters With Chemotherapy for the Treatment of Locally Advanced and Metastatic Pancreatic Cancer","has_exemption":false,"start_date":"2025-06-17","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Alpha Tau Medical LTD.","sponsor_slug":"alpha-tau-medical-ltd","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07016074","publication_url":"https://clinicaltrials.gov/study/NCT07016074","title":"Inorganic Nitrate (NaNO3) Prevention of Contrast-Associated Acute Kidney Injury","has_exemption":false,"start_date":"2025-06-30","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"University of Michigan","sponsor_slug":"university-of-michigan","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07211633","publication_url":"https://clinicaltrials.gov/study/NCT07211633","title":"A Phase 3, Non-Inferiority, Randomized, Open-Label, Parallel Group, Multicenter Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Safety, Radiological and Clinical Effects of Subcutaneous Ublituximab Versus Intravenous Ublituximab in Patients With Multiple Sclerosis","has_exemption":false,"start_date":"2025-07-09","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"TG Therapeutics, Inc.","sponsor_slug":"tg-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07147647","publication_url":"https://clinicaltrials.gov/study/NCT07147647","title":"Efficacy of Direct Selective Laser Trabeculoplasty (DSLT) for Reducing Intraocular Pressure in Non-Caucasian Open Angle Glaucoma Patients","has_exemption":false,"start_date":"2025-07-16","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Select Eye Care","sponsor_slug":"select-eye-care","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07020936","publication_url":"https://clinicaltrials.gov/study/NCT07020936","title":"Safety and Feasibility Testing of AIDANET in Children Age 6-13 Years","has_exemption":false,"start_date":"2025-07-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Mark D. DeBoer, MD, MSc., MCR","sponsor_slug":"mark-d-deboer-md-msc-mcr","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT02880163","publication_url":"https://clinicaltrials.gov/study/NCT02880163","title":"Reducing Exsanguination Via In-Vivo Expandable Foam","has_exemption":false,"start_date":"2025-08-07","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Arsenal Medical, Inc.","sponsor_slug":"arsenal-medical-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07148414","publication_url":"https://clinicaltrials.gov/study/NCT07148414","title":"Phase 2 Study to Assess the Efficacy and Safety of SPY002-072 in Adults With Moderately to Severely Active Rheumatologic Disease","has_exemption":false,"start_date":"2025-08-21","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Spyre Therapeutics, Inc.","sponsor_slug":"spyre-therapeutics-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07167758","publication_url":"https://clinicaltrials.gov/study/NCT07167758","title":"A Phase 2a, Randomized, Multicenter, Double-Blind, Placebo- Controlled Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Multiple Subcutaneous Doses of TRIV-509 in Adults With Moderate to Severe Atopic Dermatitis","has_exemption":false,"start_date":"2025-08-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Triveni Bio","sponsor_slug":"triveni-bio","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07493460","publication_url":"https://clinicaltrials.gov/study/NCT07493460","title":"Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines","has_exemption":false,"start_date":"2025-08-26","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Washington University School of Medicine","sponsor_slug":"washington-university-school-of-medicine","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07122193","publication_url":"https://clinicaltrials.gov/study/NCT07122193","title":"A Phase 3, Randomized, Parallel-Group, Double-Blind, Multicenter Study Investigating the Safety and Efficacy of NT 201 Compared With Placebo in Adult Participants With Moderate to Severe Platysma Prominence in the United States","has_exemption":false,"start_date":"2025-08-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Merz North America, Inc.","sponsor_slug":"merz-north-america-inc","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07191483","publication_url":"https://clinicaltrials.gov/study/NCT07191483","title":"A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of KYN-5356 as Adjunctive Treatment in Adults With Cognitive Impairment Associated With Schizophrenia","has_exemption":false,"start_date":"2025-08-27","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Kynexis B.V.","sponsor_slug":"kynexis-bv","status":"ongoing","is_pact":false,"days_late":null},{"registry_id":"NCT07112443","publication_url":"https://clinicaltrials.gov/study/NCT07112443","title":"A Phase 3 Randomized, Controlled Study to Assess the Efficacy and Safety of NVD003 Compared With Iliac Crest Bone Graft in Pediatric Participants Treated Surgically for Congenital Pseudarthrosis of the Tibia","has_exemption":false,"start_date":"2025-09-02","completion_date":"2026-10-31","has_results":false,"results_due":false,"sponsor_name":"Novadip Biosciences","sponsor_slug":"novadip-biosciences","status":"ongoing","is_pact":false,"days_late":null}]}